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Abstract 
During the invasion of a susceptible host, Tobacco mosaic virus (TMV) transports its 
RNA genome from sites of viral synthesis into neighbouring cells, thus potentiating the 
spread of infection. In many systems, RNA trafficking is known to be a highly 
coordinated process, often involving the complex interplay of numerous factors. In 
plants, however, the mechanisms that govern RNA transport are not well understood. 
Since viruses have a propensity to exploit pre-existing host machinery for their own 
purposes, TMV has become a popular model system for the study of RNA trafficking 
in plants. TMV viral RNA (vRNA) is thought to be transported as a ribonucleoprotein 
(RNP) with the virally encoded movement protein (MP). Localization studies have 
demonstrated a temporal redistribution of MP from endoplasmic reticulum (ER)-
derived replication bodies onto microtubules (MTs) at mid to late stage of infection. A 
functional link between the association of MP with microtubules (MT) and RNA 
trafficking has been established, and furthermore, this association does not require 
other viral components or plant-specific factors, thereby indicating a direct interaction 
between MP and MTs. In vitro, purified MP interacts directly with preformed, 
dynamically suppressed MTs and has no requirement for MT polymerization or 
polymer-specific structural forms. Immunohistochemical studies indicate that MP may 
interact with the extreme C-termini of a- and b-tubulin, possibly forming a stabilizing 
sheath. Consistent with the proposal that MP functions as a structural microtubule-
associated protein (MAP), MP:MT complexes assembled in vitro are highly stable. A 
possible functional overlap between the putative RNA and MT binding domains of MP 
has been identified, and although MP:MT complexes are unlikely to support RNA 
transport directly, such complexes have been implicated to modulate MT-dependent 
molecular motor activity. Collectively, in vitro data are in support of the observation 
that MP associates with MTs to high amounts, leading to the hypothesis that MP-
mediated RNA transport and the MP:MT interaction are related, yet functionally 
distinguishable processes. Furthermore, based on the similarity of MP to endogenous 
MAPs, a new model is proposed in which MP-mediated trafficking may occur in the 
form of a translationally competent ER-vesicle, concurrent with the deployment of MP 
to the MT surface. 
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1 Introduction 
1.1 Overview of RNA trafficking and localization 
In order for multicellular organisms to regulate their biological activities, appropriate 
information must be communicated in a coordinated manner between tissues, cells and 
subcellular compartments. The nature of such information varies widely, however, 
eukaryotes have developed sophisticated strategies which allow them to regulate 
cellular and developmental events by the selective trafficking and localization of RNA 
(Chartrand et al., 2001; Jansen, 2001; Palacios and St Johnston, 2001; Kloc et al., 
2002; Okita and Choi, 2002). RNA localization is known to occur in a variety of cell 
types and is thought to be essential for processes such as cell-fate determination, polar 
cell growth and spatially restricted protein expression. Intracellular RNA localization 
can occur via several mechanisms, which include random diffusion/cytoplasmic 
streaming and directional transport on cytoskeleton elements. In both plants and 
animals, examples of intercellular RNA trafficking have been described, and in 
addition, certain endogenous plant RNAs have been demonstrated to move 
systemically, suggesting that RNA trafficking may be involved in non-cell-autonomous 
signaling. Accumulating evidence suggests that endogenous RNA trafficking is 
mediated by the interaction of specific trans-acting factors with signal elements present 
within the RNA (Palacios and St Johnston, 2001). A number of localized RNAs are 
found in large ribonucleoprotein (RNP) complexes (Ferrandon et al., 1994; Knowles et 
al., 1996; Mouland et al., 2001), and in addition to directing RNAs to their respective 
destinations, such RNPs may also be involved in translational regulation (Cooperstock 
and Lipshitz, 2001; Johnstone and Lasko, 2001). RNA trafficking and localization is 
not only restricted to endogenous RNAs. A number of RNA viruses found in both 
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animal and plant kingdoms are also known to utilize components of the host transport 
machinery, presumably in an effort to facilitate the replication and intercellular spread 
of their genomes.  
1.2 Examples of RNA trafficking and localization 
1.2.1 Ash-1 mRNA in Saccharomyces cerevisiae 
During cell division in budding yeast, mating-type switching (Strathern and 
Herskowitz, 1979) is repressed by the asymmetric accumulation of transcriptional 
regulator Ash1p in daughter cell nuclei. (Bobola et al., 1996; Sil and Herskowitz, 
1996). Spatial segregation of Ash1p involves the localization of Ash-1 transcripts at the 
distal bud tip during late anaphase (Long et al., 1997; Takizawa et al., 1997) and has 
been demonstrated to require the gene encoding Myo4p, a class V myosin (Haarer et 
al., 1994; Jansen et al., 1996). By using a yeast mutant in which the myosin binding 
site on actin is disrupted, it was found that Ash-1 transcripts no longer localized 
asymmetrically to the daughter cell (Long et al., 1997), and furthermore, Ash-1 mRNA 
appeared to be randomly distributed throughout both mother and daughter cells 
following treatment with the actin-depolymerizing drug Latrunculin-A (Takizawa et 
al., 1997), again suggesting the involvement of an actin-dependent mechanism. 
Compelling evidence to support the role of Myo4p motor transport in Ash-1 mRNA 
trafficking was provided by the observation that Myo4p colocalizes with Ash-1 
mRNA-containing particles (Bertrand et al., 1998; Takizawa and Vale, 2000), and in 
living cells, directly mediates Ash-1 mRNA movement into the bud tip (Bertrand et al., 
1998; Beach et al., 1999). It has emerged that a number of accessory proteins are also 
required for Ash-1 translocation, and these are thought to be involved in anchoring Ash-
1 transcripts to Myo4p, stabilizing the actin cytoskeleton and possibly maintaining 
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translational silence until Ash-1 mRNA reaches the bud tip (Munchow et al., 1999; 
Bohl et al., 2000; Long et al., 2000; Takizawa and Vale, 2000).  
1.2.2 MBP mRNA in oligodendrocytes 
Myelin basic protein (MBP) mRNA has been found to localize to the membranes and 
myelin of oligodendrocyte peripheral processes, up to 50 mm from the site of RNA 
synthesis (Kristensson et al., 1986; Verity and Campagnoni, 1988). By injecting a 
fluorescently labeled MBP mRNA into cultured mouse oligodendrocytes, it was 
observed that transcripts formed granular structures within the perykaryon cytoplasm 
which traveled towards the cellular periphery along narrow processes at an average 
speed of ~ 0.2 mm/sec (Ainger et al., 1993). A similar distribution of endogenous MBP 
mRNA was also found using in situ hybridization techniques, and furthermore, it was 
observed that upon reaching the cell periphery, the movement of MBP mRNA-
containing granules was no longer directional, possibly suggesting the existence of a 
multi-step mechanism. Subcellular fractionation experiments indicated that MBP 
mRNA was associated with cytoskeleton elements within the cellular processes, and 
interestingly, it was found that treatment with the microtubule destabilizing drug 
Nocodazole inhibited the translocation of MBP mRNA, however, disruption of the 
actin cytoskeleton had no discernible effect (Carson et al., 1997). By inhibiting 
kinesin-1 expression using an anti-sense oligonucleotide, it was also found that MBP 
mRNA localization was inhibited. Collectively, these data strongly indicate that 
anterograde MBP mRNA trafficking in oligodendrocytes requires intact microtubules 
and most likely involves the positive-end directed motor protein kinesin-1. 
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1.2.3 Pair-rule mRNAs in the Drosophila blastoderm embryo 
During interphase 14 of D. melanogaster embryogenesis, the monolayer of nuclei 
found at the cortex of the blastoderm embryo subdivides into apical, nuclear and basal 
compartments (Fullilove and Jacobson, 1971; Rickoll, 1976; Turner and Mahowald, 
1976). At this stage, RNA transcripts of the pair-rule genes localize to the apical 
periplasm in seven transverse stripes along the anteroposterior axis, thereby 
establishing segmental patterning (Hafen et al., 1984; Edgar et al., 1986). In two 
independent studies, disruption of the microtubule cytoskeleton with colcemid caused 
both endogenous pair-rule RNA fushi tarazu (ftz), and injected ftz mRNA to disperse 
into all three of the blastoderm layers (Edgar et al., 1987; Lall et al., 1999). 
Furthermore, it was found that when preincubated with human or Drosophila 
embryonic nuclear extract, injected ftz mRNAs rapidly localized to the apical periplasm 
in a microtubule-dependent manner (Lall et al., 1999). Since MTs radiate from apically 
positioned centrosomes in blastoderms, it was speculated that pair-rule mRNA 
transport requires the minus-end directed motor protein dynein. It was found that upon 
coinjection of ftz mRNA with anti-dynein heavy chain antibodies, almost complete 
inhibition of ftz localization occurred (Wilkie and Davis, 2001). Moreover, through the 
use of hypomorphic dynein mutants, or by disrupting the dynein-dynactin complex 
with an excess of dynamitin (Echeverri et al., 1996), trafficking of ftz RNA could be 
severely impeded, thereby strongly indicating that active motor transport potentiates 
pair-rule mRNA translocation. 
1.2.4 Vg1 mRNA in Xenopus oocytes 
In X. laevis oocytes, specific maternal RNAs become localized to either the animal or 
vegetal cortices, thereby leading to cell polarization and formation of the primary 
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developmental axis in fertilized embryos (Kloc et al., 2001). Vg1 mRNA is distributed 
throughout the oocyte early during oogenesis (stages 1 and 2) and localizes to the 
vegetal cortex from stage 3 onwards (Melton, 1987; Forristall et al., 1995). Using in 
situ hybridization experiments, it was observed that following treatment with the 
microtubule disrupting drugs colchicine or nocodazole, Vg1 mRNA no longer localized 
to the vegetal cortex during embryogenesis stage 3 (Yisraeli et al., 1990). In contrast, 
Vg1 mRNA remained localized to the vegetal hemisphere during stages 5 and 6 of 
oogenesis, regardless of microtubule disruption, although transcripts became 
mislocalized upon disruption of actin filaments with cytochalasin B. These findings 
correlated with fractionation experiments demonstrating Vg1 mRNA release from 
detergent-insoluble fractions following nocodazole treatment at stage 3, and 
cytochalasin treatment at stages 5/6, respectively. Furthermore, these data support the 
notion of a two-step localization mechanism in which Vg1 mRNA is trafficked to the 
vegetal hemisphere in a microtubule-dependent manner and anchored proximal to the 
cortex using an actin-based mechanism. In addition, it was found that Vg1 association 
with microtubules requires Vg1RBP/Vera, a protein which specifically recognizes and 
co-localizes with Vg1 mRNA at the vegetal cortex (Schwartz et al., 1992; Elisha et al., 
1995; Deshler et al., 1997). It has been speculated that Vg1 mRNA trafficking may 
require minus-end directed motor trafficking along MTs which have their plus-ends 
oriented towards the cell interior (Pfeiffer and Gard, 1999). Although such a motor 
protein has yet to be identified, is has been demonstrated that Vg1RBP/Vera co-
fractionates with rough endoplasmic reticulum (RER) and Vg1 mRNA localizes to a 
subdomain of the vegetal RER during oogenesis states 2 and 3 (Deshler et al., 1997). It 
is therefore conceivable that, although localization to the cortex requires the association 
of both Vg1RBP/Vera and Vg1 mRNA with intact microtubules, actual translocation in 
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fact results from a microtubule-based membrane trafficking pathway (Dabora and 
Scheetz, 1988; Lee and Chen, 1988; Allan and Vale, 1994; Waterman-Storer et al., 
1995). 
1.2.5 Bicoid and Oskar RNAs in Drosophila oogenesis 
Drosophila oocytes develop in an egg chamber consisting of 15 nurse cells and an 
oocyte, surrounded by a monolayer of follicle cells. The nurse cells are connected to 
each other, and also to the anterior of the oocyte by large cytoplasmic bridges called 
ring canals. During stages 1-7 of oogenesis, bicoid and oskar mRNAs are synthesized 
in the nurse cells and transported into the oocyte. Later during mid-stages (8/9), 
anteroposterior patterning is specified in part by the anterior localization of bicoid 
mRNA and posterior localization of oskar mRNA, respectively (St Johnston et al., 
1989; Wilsch-Brauninger et al., 1997; Riechmann and Ephrussi, 2001; van Eeden et 
al., 2001). It has been demonstrated that intact microtubules are required for trafficking 
and localization of these transcripts (Pokrywka and Stephenson, 1991; Clark et al., 
1994; Pokrywka and Stephenson, 1995), and in addition, several indirect lines of 
evidence support the role of molecular motors in bicoid and oskar mRNA localization 
(Brendza et al., 2000; Schnorrer et al., 2000; Palacios and St Johnston, 2002). During 
mid-oogenesis, microtubules are normally oriented with their minus-ends proximal to 
the anterior pole (Theurkauf et al., 1992). Using a Drosophila mutant with a 
misorganized microtubule cytoskeleton, the presence of microtubule minus-ends could 
be correlated with bicoid mRNA localized to both poles, thereby suggesting a minus-
end directed motor transport mechanism (Clark et al., 1997; Schnorrer et al., 2000). 
Furthermore, disruption of dynein activity by the overexpression of dynamitin led to 
bicoid mRNA mislocalization, apparently without compromising the microtubule 
  
7
 
organization (Duncan and Warrior, 2002; Januschke et al., 2002). Similarly, oskar 
mRNA was mislocalized in kinesin deficient mutant Drosophila oocytes (Brendza et 
al., 2000), however, direct observations of motor-dependent RNA trafficking have yet 
to be described. Interestingly, it has been proposed that kinesin-dependent ooplasmic 
streaming (Gutzeit, 1986; Bohrmann and Biber, 1994; Palacios and St Johnston, 2002) 
may contribute to the positioning of oskar transcripts during late stages of oogenesis 
(Glotzer et al., 1997). When injected into oocytes, fluorescent oskar RNAs appeared to 
enter the directional streaming flow and accumulate at the posterior pole, an 
observation that correlates with the loss of anteroposteriorly organized microtubules 
during late oogenesis (Theurkauf et al., 1992). Although rather speculative, this theory 
does highlight the necessity for both trafficking and anchoring machinery during RNA 
localization, which in the case of bicoid and oskar mRNA transport, is reflected by the 
fact that over 20 accessory factors are likely to be involved (Martin et al., 2003). 
1.2.6 Protamine-1 mRNA in mouse spermatids 
Independent lines of evidence support the idea that, in order to attain phenotypic 
equivalency during spermatogenesis, haploid mice spermatids are able to transmit 
certain mRNAs directly through intercellular crossbridges. Indirect evidence for 
intercellular RNA transport came from studies using transgenic mice, hemizygous for a 
chimaeric gene containing the transcriptional regulatory sequences of protamine-1 
(Prm-1) and the coding region for human growth hormone (hGH). It was found that in 
mice where only half of the germ cells carried the transgene, the hGH gene product 
could be detected in over 90 % of the spermatids, The authors could not, however, 
differentiate between translocation of the RNA transcript or the protein itself (Braun et 
al., 1989). By exploiting a karyotype of mice that undergo anomalous meiotic 
segregation, Caldwell and Handel were able to demonstrate that intercellular Prm-1 
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trafficking was indeed likely to occur. In populations of spermatids that contained 
individuals nulli- uni- and disomic for the Prm-1 gene, the distribution of Prm-1 
mRNA in whole testis sections was found to be indistinguishable from that of control 
mice (Caldwell and Handel, 1991). Interestingly, protamine-1 RNA contains so-called 
Y and H sequences (Han et al., 1995), which are known to occur in a number of RNAs 
associated with mouse testis/brain RNA-binding protein (TB-RBP). Using 
immunocytochemical and in situ labeling techniques, TB-RBP and AKAP4 (an X-
linked RNA containing Y and H sequences) could be co-localized in the spermatid 
cytoplasm, and furthermore, within intercellular crossbridges (Morales et al., 2002). 
Although inconclusive, this might suggest that a ribonucleoprotein (RNP) transport 
complex is involved in AKAP4 trafficking between spermatozoa. 
1.2.7 Intercellular RNA trafficking in plants 
Plant cells are separated from each other by an extensive extracellular matrix or cell 
wall. Although the cell wall is not totally impervious (Baron-Epel et al., 1988), it is 
likely to hinder the direct cell-to-cell communication of relatively large molecules such 
as mRNAs. Furthermore, because plant cells do not migrate, their spatial environment 
becomes a major determinant of cell fate (Steeves and Sussex, 1989; Van den Berg et 
al., 1995), and therefore, plants must be able to communicate efficiently between cells 
and tissues in order to orchestrate their development. To facilitate this, neighbouring 
plant cells are connected via plasmodesmata (Pd), membrane-contiguous cytoplasmic 
continuities (Robards and Lucas, 1990). Moreover, due to this symplasmic continuum 
between groups of cells, it has been proposed that plants behave as supracellular 
organisms (Lucas and van der Schoot, 1993; Lucas et al., 1995; Jackson and Hake, 
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1997; Zambryski and Crawford, 2000), with the capacity to regulate gene expression 
above the single cell level (Lucas et al., 2001; Haywood et al., 2002; Heinlein, 2002a).  
1.2.7.1 Long distance RNA trafficking and developmental regulation 
The potential role of intercellular RNA trafficking in developmental and physiological 
processes was highlighted by the finding that mRNA transcripts of phloem-specific 
leaf sucrose transporter (SUT-1) had the apparent capacity to move cell-to-cell (Kühn 
et al., 1997). Using in situ hybridization techniques, it was possible to localize Sut-1 
mRNA to the companion cells (CC), enucleate sieve elements (SE) and plasmodesmata 
of potato leaf phloem. Furthermore, since overall SUT-1 expression is repressed by an 
antisense construct under the control of a CC-specific promoter (Kuhn et al., 1996), it 
was reasonably speculated that Sut-1 mRNA is transcribed in the CC before moving 
through the Pd into the SEs. Intercellular RNA trafficking has also been proposed for 
Knotted-1 (KN-1), a homeobox transcriptional regulator known to be involved in cell-
fate determination in maize vegetative and floral meristems (Sinha, 1999). KN-1 
protein has been directly demonstrated to move between cells of the Arabidopsis shoot 
apex (Kim et al., 2002), and furthermore, upon co-injection of tobacco mesophyll cells 
with E.coli produced KN-1 protein, in vitro transcribed Kn-1 sense RNA transcripts 
were observed to move cell-to-cell (Lucas et al., 1995). Although a direct functional 
relationship between Kn-1 RNA movement and cell differentiation was not determined, 
the authors were able to demonstrate that intercellular RNA movement was sequence-
specific in this case. Using a similar microinjection approach, Xoconostle-Cazares et 
al. could show that when CmPP16 RNA from pumpkin and the corresponding 
CmPP16 protein were co-injected into mesophyll cells, rapid intercellular RNA 
movement occurred (Xoconostle-Cazares et al., 1999). Furthermore, using RT-PCR, it 
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was possible to detect CmPP16 transcripts in the phloem sap of cucumber scions 
heterografted onto pumpkin rootstocks, thereby demonstrating long-distance RNA 
trafficking via the plant vasculature. The role of RNA as a cell-non-autonomous 
signaling macromolecule is supported by the observation that following long distance 
transport, RNAs known to be involved in developmental processes can both 
accumulate in meristematic tissues (Ruiz-Medrano et al., 1999), and apparently 
influence leaf morphology (Kim et al., 2001). Kim et al. exploited a dominant leaf 
mutant of tomato called Mouse ears (Me) in which anomalous fusion of the KNOX 
gene LeT6 to the 5’ coding and promoter region of Pyrophosphate-dependent 
phosphofructokinase (PFP) results in overexpression of PFP-LeT6 transcripts in leaves 
and altered leaf morphology (Chen et al., 1997; Kim et al., 2001). Interestingly, when 
wild-type scions were heterografted onto Me mutant rootstocks, new leaves in the scion 
developed the Mouse ears morphology, suggesting that the Me phenotype was graft 
transmissible. Furthermore, the distribution of PFP-LeT6 transcript in the shoot apical 
meristem of heterografted scions was reminiscent of that found in non-grafted Me 
plants, suggesting that spatial patterning of RNA may influence developmental 
consequences at the shoot apex. Although these data provided strong correlative 
evidence that PFP-LeT6 RNA was the signaling molecule responsible for the Me 
phenotype in heterografted scions, it remains plausible that overexpression of this 
homeotic gene may have led to the misregulation of other developmental signals, such 
as phytohormones (Ori et al., 1999; Tsiantis, 2001).  
1.2.7.2 Systemic RNA trafficking and gene silencing 
In addition to plant developmental coordination, intercellular RNA trafficking has also 
been implicated in the potentiation of systemic post-transcriptional gene silencing 
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(PTGS), a sequence-specific defense mechanism by which plants target and degrade 
RNAs that are perceived to be foreign or aberrant (Lucas et al., 2001; Waterhouse et 
al., 2001; Mlotshwa et al., 2002). Direct evidence for a systemic silencing signal was 
provided by grafting experiments where spontaneous gene silencing in transgenic 
tobacco rootstocks was transmitted into isogenic scions that did not display silencing 
prior to the grafting procedure (Palauqui et al., 1997). In addition, it was found that 
systemic silencing could be initiated in transgenic tobacco by the introduction of DNA 
which contained sequences homologous to the transgene (Voinnet and Baulcombe, 
1997). The apparent absence of exogenous DNA in systemically silenced tissue 
supported the concept of a mobile silencing signal, and moreover, since the silencing 
events appeared to be sequence-specific in both cases, the systemic signal was 
proposed to be a nucleic acid. Consistent with this hypothesis, short (21-26 nt) double-
stranded (ds) RNAs with sequence homology to silenced transcripts have been found to 
accumulate in silenced tissues (Hamilton and Baulcombe, 1999; Hamilton et al., 2002), 
and although thought to be the cleavage products of longer dsRNA precursors (Tang et 
al., 2003), these so-called small interfering RNAs (siRNAs) are sufficient to elicit 
sequence-specific gene silencing in both mammalian and plant systems (Elbashir et al., 
2001; Klahre et al., 2002; Vanitharani et al., 2003). The exact nature of the mobile 
silencing signal has yet to be elucidated, however, since evidence for systemic 
trafficking of DNA or long dsRNAs is mostly lacking, it remains a plausible hypothesis 
that long distance gene silencing is mediated by siRNAs or related RNA species. 
1.2.8 Intracellular RNA trafficking in plants 
In plants, the mechanisms which govern intracellular trafficking and localization of 
endogenous RNA remain poorly understood. One of the best studied examples, 
however, is the localization of storage protein mRNAs to subcompartments of the 
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rough endoplasmic reticulum (RER) of rice endosperms. During seed development, 
endosperms accumulate two classes of storage protein, glutelins and prolamines.  
Following translation on polysomes (Kim et al., 1993; Okita et al., 1994; Okita and 
Rogers, 1996), glutelin protein is sequestered to a vacuolar compartment via the golgi 
complex, and prolamine forms so-called protein bodies within the lumen of 
intracisternal RER (Krishnan et al., 1986; Yamagata et al., 1986). Biochemical studies 
demonstrated that while glutelin mRNA species predominated in cisternal-ER (C-ER) 
derived vesicles, ER fractions enriched for protein bodies (PB-ER), only contained 
prolamine mRNAs (Yamagata et al., 1986; Yamagata and Tanaka, 1986). The non-
random distribution of these transcripts was directly confirmed by in situ hydridization 
experiments (Li et al., 1993), and moreover, by substitution of the prolamine 3’-
untranslated region (3’-UTR) for that of glutelin, it was shown that the prolamine 
chimera was mislocalized to sites reminiscent of endogenous glutelin transcripts (Choi 
et al., 2000). This suggested that sequence-specific signaling elements are involved in 
mRNA localization during endosperm development, and moreover, disruption of the 
protamine AUG start codon resulted in severe RNA mislocalization, indicating that 
protamine mRNA may translocate as a ribonucleoprotein (RNP) complex, and possibly 
requires translation initiation factors for appropriate ER-targeting. Although prolamine 
mRNAs have been shown to associate with detergent-resistant cell fractions containing 
PBs and cytoskeleton elements (Muench et al., 1998), direct evidence linking 
prolamine mRNA trafficking and active transport is lacking.  A putative trans-acting 
factor has been identified, however, and this 120 kDa protein binds the prolamine 3’-
UTR and co-sediments with the actin cytoskeleton (Sami-Subbu et al., 2001). 
Nevertheless, due to the fact that both polysomes (Davies et al., 1991) and ER-
membranes (Dabora and Scheetz, 1988; Lee and Chen, 1988; Allan and Vale, 1994; 
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Waterman-Storer et al., 1995) have been described to associate with cytoskeletal 
filaments, it remains unclear what role the cytoskeleton plays in prolamine localization, 
and indeed, whether these subcellular compartments are mutually exclusive during 
endosperm development. 
1.3 Tobacco Mosaic Virus (TMV) as a model to study 
intracellular RNA trafficking in plants 
In plants, the molecular mechanisms responsible for intracellular RNA transport 
remain largely unknown. Evidence from other systems indicates that RNA trafficking 
and localization is a highly coordinated process, capable of directing transcripts to their 
respective destinations in an efficient and sequence-specific manner. Although not 
ubiquitous, cytoskeleton-dependent mechanisms appear to be a common feature of 
intracellular RNA transport in a variety of cell types. Given the propensity of viruses to 
exploit pre-existing host machinery, it is not surprising to find that among others, HIV 
(Kimura et al., 1996; Liu et al., 1999; Mouland et al., 2000; Mouland et al., 2001), 
Vaccinia (Hollinshead et al., 2001; Mallardo et al., 2001; Rietdorf et al., 2001) and 
Herpes simplex viruses (Döhner et al., 2002; Mabit et al., 2002; Martin et al., 2002) 
also utilize cytoskeleton-based transport in order to facilitate the translocation of their 
viral components through the cytoplasm (Sodeik, 2000; Enquist, 2002). Based on this 
precept, TMV may also exploit an endogenous transport pathway, and therefore, 
provide a useful tool for elucidating the host components involved in plant RNA 
trafficking. TMV is a single stranded positive-sense RNA virus which replicates on 
ER-derived membranes (Más and Beachy, 1999) before exporting its genome into 
neighbouring cells via plasmodesmata (Tomenius et al., 1987; Atkins et al., 1991). 
Since these processes have no requirement for coat protein (CP), it appears that TMV 
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viral RNA (vRNA) can move both intra- and intercellularly in a non-encapsidated form 
(Dawson et al., 1988; Heinlein et al., 1998). In addition to modulating the size 
exclusion limit of Pd (Wolf et al., 1989; Oparka et al., 1997), the 30 kDa movement 
protein (MP) of TMV is proposed to mediate vRNA transport in the form of a viral 
ribonucleoprotein complex (Dorokhov et al., 1983; Dorokhov et al., 1984; Citovsky et 
al., 1990), and therefore, MP may represent an indirect marker for the presence of 
vRNA during TMV infection. In support of this hypothesis, preliminary studies show 
that during TMV infection, the distribution of vRNA in living plant cells is very similar 
to that of MP (Boyko et. al, unpublished observation), an observation previously found 
in TMV-infected BY-2 protoplasts (Más and Beachy, 1999). 
1.3.1 Structure and organization of the TMV genome 
TMV virions are composed of a 6.4 kb single-stranded, positive-sense RNA which is 
encapsidated with 2160 helically arranged coat protein (CP) subunits. The genomic 
RNA is capped with 7-methyl guanosine at the 5’ terminus and forms a histidine-
accepting transfer RNA (tRNA)-like structure within the 3’-untranslated region (3’-
UTR). Downstream of the 69 nucleotide leader sequence are four open reading frames 
(ORFs) encoding the 17.5 kDa CP and three non-structural proteins of 126, 183 and 30 
kDa, respectively. The 126 kDa and 183 kDa proteins are translated directly from 
genomic RNA and constitute the replicase function of TMV (Lewandowski and 
Dawson, 2000). The 126 kDa protein is translated from ORF1 and the 183 kDa protein 
results from read-through of the amber stop codon which terminates translation of the 
126 kDa protein. The CP and 30 kDa movement protein (MP) are translated from 
subgenomic RNAs that are produced during virus replication.  
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1.3.2 TMV infection cycle 
Following entry of TMV into a host cell (Shaw, 1999), virus infection is thought to 
initiate through a combination of co-translational and co-replicational disassembly 
mechanisms. It was shown that in vitro, treatment of virions with mild alkali conditions 
resulted in the rapid exposure of ~ 200 nucleotides from the 5’-end of genomic RNA 
(Mundry et al., 1991). Furthermore, using a cell-free translation system, it was found 
that translation of replicase protein was greatly enhanced by pH and ionic conditions 
similar to those found in the plant cytoplasm, thereby supporting the idea of  5’ ® 3’ 
co-translational disassembly in vivo (Wilson, 1984). In addition, it was demonstrated 
that 3’ ® 5’ disassembly of TMV coincided with synthesis of progeny negative-strand 
RNA and required the presence of the replicase proteins (Wilson, 1985). Therefore, it 
is likely that the processes of viral disassembly, replicase translation and RNA 
synthesis are coupled in vivo. Replication of TMV RNA proceeds through replicase-
dependent synthesis of a complementary negative-strand using the positive-strand as a 
template. Subsequently, progeny positive strands are synthesized using the negative 
strand as a template, as are the subgenomic RNAs encoding MP and CP (Buck, 1999). 
In tobacco protoplasts, negative strand synthesis halts 6-8 hours following inoculation, 
however, positive strands continue to be synthesized for a further 8-10 hours (Ishikawa 
et al., 1991). In addition to genomic- and subgenomic-length positive-strand RNAs, 
replication intermediates isolated from TMV-infected plants appear to include 
genomic-length double-stranded RNAs and a number of partly double-stranded and 
partly single-stranded RNAs (Nilsson-Tillgren, 1970; Jackson et al., 1971). It remains 
unclear, however, whether such double-stranded RNAs (dsRNAs) were formed 
spontaneously during the RNA extraction procedure, or actually represent RNA species 
present in vivo. Considering that dsRNA can act as a potent elicitor of gene-silencing 
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(Bass, 2000), one might expect TMV to limit dsRNA formation throughout infection. 
During early to mid-infection, MP is expressed transiently and accumulates to 
relatively low levels (Lehto et al., 1990). In contrast, CP accumulates to high amounts 
later during replication (Siegel et al., 1978; Ooshika et al., 1984; Watanabe et al., 
1984; Lehto et al., 1990), and when synthesis of negative-strand RNA has ceased, 
encapsidates the genomic positive-strand RNA to form virions (Aoki and Takebe, 
1975; Palukaitis et al., 1983).  
1.3.3 The role of MP during vRNA trafficking 
Following infection of tobacco BY-2 protoplasts with a TMV-derivative lacking the 
genes for MP and CP, it was found that TMV-specific RNAs continued to accumulate, 
indicating that neither coding sequence contained cis-acting elements required for 
replication (Meshi et al., 1987). Furthermore, analysis of local lesion development in 
TMV-infected N. tabacum demonstrated that cell-to-cell vRNA spread was abolished  
by mutations in the MP gene, but not the CP gene (Meshi et al., 1987; Dawson et al., 
1988). More recent studies have unequivocally proven that the entire CP gene is 
dispensable for cell-to-cell movement of TMV (Heinlein et al., 1998). The role of MP 
in vRNA trafficking is further supported by functional complementation studies in 
which transgenically or virally expressed MPs have the ability to facilitate intercellular 
spread of TMV-derivatives encoding transport-defective MPs (Deom et al., 1987; Holt 
and Beachy, 1991). Using a variety of experimental approaches, it was also found that 
MP has the intrinsic ability to target Pd (Tomenius et al., 1987; Atkins et al., 1991; 
Ding et al., 1992; Moore et al., 1992) and rapidly increase their size exclusion limit 
(Wolf et al., 1989; Waigmann et al., 1994). This may indicate that MP directly 
interacts with putative Pd-targeting factors, however, it was found that MP mutants 
unable to mediate the cell-to-cell spread of TMV can still target and accumulate at Pd 
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(Boyko et al., 2000a; Boyko et al., 2000c). Although inconclusive, this would appear 
to suggest that such loss of movement function corresponds to events preceding Pd 
targeting of the TMV genome, thereby reaffirming the role of MP during intracellular 
vRNA transport. 
1.3.4 Transport as a ribonucleoprotein complex (RNP) 
MP purified from E.coli has been demonstrated to bind both ssRNA and ssDNA in 
vitro (Citovsky et al., 1990; Citovsky et al., 1992; Li and Palukaitis, 1996). Such 
complexes assume an unfolded, elongated structure which is consistent in diameter (~ 
2 nm) with dilated Pd (Citovsky et al., 1992; Drygin et al., 1998; Kiselyova et al., 
2001). Similar long and elongated RNP complexes have been isolated from tobacco 
plants infected with wild-type TMV (Dorokhov et al., 1983), but could not be extracted 
from plants inoculated with virus encoding a temperature-sensitive mutant of MP, and 
grown at non-permissive temperature (Dorokhov et al., 1984). The fact that MP binds 
ssRNA in a sequence non-specific manner may also account for the observation that 
MPs from certain viruses are functionally interchangeable (Deom et al., 1987) and that 
MP can facilitate the cell-to-cell spread of a number of co-injected nucleic acids 
(Fujiwara et al., 1993; Noueiry et al., 1994; Waigmann et al., 1994; Ding et al., 1995). 
MP:vRNA complexes formed in vitro are non-translatable when electroporated into 
tobacco protoplasts or when added to in vitro translation reactions (Karpova et al., 
1997). Translation repression is abolished when MP is phosphorylated by protein 
kinase-C or by a plant cell-wall-associated kinase (Karpova et al., 1999), and since in 
vitro assembled vRNPs can also be translated in planta, it has been speculated that 
these complexes are modified during their passage through the Pd (Karpova et al., 
1997). Although direct observations of MP-mediated vRNA trafficking have yet to be 
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made, the collective evidence does support the hypothesis that MP and RNA are co-
transported as a vRNP complex. 
1.3.5 Subcellular distribution of MP during infection 
When fused with the green fluorescent protein (GFP) of Aequorea victorea, the spatial 
distribution of MP in TMV-infected cells can be directly monitored (Heinlein et al., 
1995; Epel et al., 1996). Although the visualization of vRNA has been limited to 
indirect techniques such as in situ hybridization (Más and Beachy, 1999), inferences 
can be made as to the subcellular structures involved in vRNA trafficking by 
determining the distribution of MP:GFP and vRNA in cells at equivalent stages of 
TMV-infection. Infection of N. benthamiana with a TMV-derivative lacking the CP 
gene and encoding MP:GFP (TMV-MP:GFP) has demonstrated that the subcellular 
distribution of MP changes temporally within infected cells  (Heinlein et al., 1995; 
Oparka et al., 1997; Heinlein et al., 1998). Upon initial infection, MP:GFP localizes to 
Pd, a finding consistent with its role in mediating cell-to-cell vRNA transport (Wolf et 
al., 1989; Waigmann et al., 1994). As infection progresses, MP:GFP can be observed 
to form irregular shaped ER-derived cytoplasmic puncta, which increase in size over 
time (Heinlein et al., 1995). The disappearance of these larger cytoplasmic aggregates 
(termed inclusion bodies) coincides with the localization of MP:GFP to microtubules 
(McLean et al., 1995; Boyko et al., 2000b; Gillespie et al., 2002), and late during 
infection, MP:GFP fluorescence is again localized exclusively to Pd. With the obvious 
exception of Pd targeting, a very similar pattern of MP:GFP localization has been 
observed in TMV-MP:GFP infected BY-2 protoplasts (Heinlein et al., 1998; Más and 
Beachy, 1998). Moreover, vRNA was also shown to localize to the intersections of 
cortical and cytoplasmic ER strands, larger ER-derived bodies and microtubules in BY-
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2 protoplasts, indicating that MP and RNA localization may occur concomitantly (Más 
and Beachy, 1999). 
1.3.5.1 Endomembrane association 
In addition to MP and vRNA, the ER-containing inclusion bodies formed during 
infection with TMV-MP:GFP also contain replicase proteins (Más and Beachy, 1999). 
It is thought that these bodies are formed by the transient recruitment of membranes 
from the cortical ER network, coinciding with the accumulation MP (Heinlein et al., 
1998; Reichel and Beachy, 1998). Furthermore, the reversion of aggregated ER back to 
tubular ER occurs concurrently with the apparent redistribution of MP:GFP onto 
microtubules (Heinlein et al., 1998; Gillespie et al., 2002). Similar changes in the 
morphology of the ER also occur upon ectopic expression of MP:GFP, indicating that 
inclusion body formation is replicase-independent (Reichel and Beachy, 1998). 
Interestingly, infection of BY-2 protoplasts with a TMV-derivative lacking the MP 
gene did not abolish the association of TMV-specific RNA with perinuclear ER, but 
did prevent the formation of large replicase-containing inclusion bodies (Más and 
Beachy, 1999). Furthermore, a deletion mutant of MP lacking 55 amino acids from the 
C-terminus does not accumulate in aggregated ER-inclusions, but can still facilitate the 
cell-to-cell movement of vRNA (Boyko et al., 2000c). This is in agreement with 
previous studies in which an MP-attenuated TMV-derivative was still able to replicate 
in planta (Meshi et al., 1987), and suggests that inclusion body formation is not 
essential to TMV function. The fact that replicase-containing complexes have been 
purified from the membrane fractions of infected cells argues that early replication 
events in fact do take place proximal to membranes (Ralph et al., 1971; Nilsson-
Tillgren et al., 1974; Watanabe and Okada, 1986; Young and Zaitlin, 1986; Young et 
al., 1987; Osman and Buck, 1996). This is supported by electron microscopy studies 
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illustrating that viral-specific inclusions contain replicase, ER and ribosomes (Martelli 
and Russo, 1977; Hills et al., 1987; Saito et al., 1987), and may indicate that at time-
points when large MP:GFP-containing bodies are observed, viral replication and cell-
to-cell spread has already taken place.  
1.3.5.2 Microtubule association 
In TMV-infected plants and protoplasts, localization of MP to microtubules (MTs) 
coincides with the reduction in size, and subsequent disappearance of MP-containing 
ER inclusion bodies (Heinlein et al., 1998). Interestingly, when infected plants are 
grown at elevated temperatures, the rate of TMV intercellular spread is enhanced 
(Lebeurier and Hirth, 1966; Dawson et al., 1975). Although the level of MP expression 
does not increase in plants grown at 32 oC (compared to 22 oC), the localization of MP 
to MTs occurs earlier during infection, indicating that efficiency of intracellular vRNA 
trafficking is linked to the redistribution of MP from sites of synthesis onto MTs 
(Boyko et al., 2000b). In BY-2 protoplasts, TMV RNA and MP have been localized to 
microtubules at equivalent stages during infection (Heinlein et al., 1998; Más and 
Beachy, 1999). In contrast, vRNA is mislocalized in protoplasts infected with TMV 
encoding a mutant of MP which does not localize to MTs, but retains RNA binding 
activity (Kahn et al., 1998). A number of MP deletion mutants have also been 
characterized in planta, and a positive correlation between the localization of MP to 
MTs and intercellular vRNA movement has been established (Kahn et al., 1998; Boyko 
et al., 2000c). Compelling evidence to support the role of MTs in vRNA trafficking 
was provided by the identification of a region within MP that shares sequence-
similarity to a-, b- and g-tubulins (Boyko et al., 2000a). Single amino acid 
substitutions within this so-called ‘tubulin mimicry domain’ are sufficient to confer 
temperature-sensitive loss of MT-association and vRNA movement. In a- and b-
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tubulins, this region of homology forms an exposed loop structure which is thought to 
mediate the lateral contacts between microtubule protofilaments (Downing and 
Nogales, 1998). Whether MP is capable of making equivalent binding contacts with 
tubulin remains unclear, however, under conditions which typically result in the 
depolymerization of MTs, such as cold, high molarity salt or Ca2+ treatments, MT 
filaments isolated from infected cells are unusually stable (Boyko et al., 2000a). 
Biochemical evidence supports the idea that MP can interact directly with MTs 
(McLean et al., 1995), and as demonstrated by transient expression assays, the ability 
of MP to associate with MTs is independent of viral replication (Heinlein et al., 1998; 
Reichel and Beachy, 1998; Kotlizky et al., 2001). Furthermore, MP associates with 
MTs when ectopically expressed in mammalian cells, thus indicating that plant-specific 
factors are not required for this interaction (Boyko et al., 2000a).  
1.3.5.3 Summary 
The collective data provide strong correlative evidence that intracellular trafficking of 
TMV RNA requires the association of MP with MTs. It is thought that MP mediates 
vRNA transport in the form of a vRNP complex, however, the direct visualization of 
actively moving vRNA has yet to be made. Nevertheless, MP associates with MTs 
when transiently expressed in plant and mammalian cells, and may mediate the 
stabilization of MT networks by a specialized direct interaction. Whether MP:MT 
complexes directly engage in vRNA transport is unclear, but given the functional 
requirement for MP to associate with MTs, further studies of this interaction may 
provide a broader understanding of the strategies employed by TMV during successful 
infection of susceptible host plants. 
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1.3.6 Thesis objectives 
The principle aim of this thesis was to elucidate the underlying mechanisms by which 
MP interacts with MTs. In order to fulfill this objective, it was imperative that we 
determine whether MP can interact directly with MTs, or whether accessory factors 
common to both plant and mammalian systems actually mediate the observed MP:MT 
association. Although direct MP:MT binding was previously demonstrated using 
purified proteins (McLean et al., 1995), the validity of these results were challenged 
following the discovery that MP preparations had a propensity to form disordered, non-
specific aggregates (Dr. L. Brill, personal communication). Furthermore, due to 
speculation regarding the involvement of a putative tubulin-mimicry domain present 
within MP (Boyko et al., 2000a), we hoped to gain an understanding of the dynamic 
behaviour of such an interaction; i.e. determine whether MP interacts with preformed 
or actively polymerizing MTs. It was hoped that by studying this interaction using 
purified proteins in vitro, the initial interpretation of data would be somewhat 
simplified, thereby providing a suitable foundation on which to base further studies 
involving multi-component complexes. If MP was indeed found to bind MTs directly, 
we wanted to characterize the interaction in more detail by determining the relative 
binding affinity and stoichiometry of the reaction. It was believed that under controlled 
conditions, comparisons could then be drawn between MP and other known 
microtubule-associated proteins (MAPs), particularly with regard to MT stability. 
Because the association of MP with MTs correlates with vRNA trafficking, it was 
crucial that we understood whether both MP and RNA could participate in the 
interaction with MTs, and whether in principle, a minimal MP:RNA:MT complex 
would be sufficient to facilitate the translocation of RNA. Several putative models have 
emerged to explain the mechanism of vRNA transport during infection (Heinlein, 
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2002b). Of these, it has been proposed that MP acts as a novel type of MAP and is 
involved in stabilizing the MT network for the purposes of providing a pathway for 
motor–based trafficking, or perhaps as a counter-defense strategy to evade host defense 
responses. In an attempt to differentiate between these potential roles, we also thought 
it important to test the ability of MT-dependent motor proteins to translocate on 
filaments heavily decorated with MP.  
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2 Materials and Methods 
2.1 Purification of overexpressed MP from E.coli 
2.1.1 Purification strategy 
2.1.1.1 Subcellular localization of MP expressed in E.coli 
Upon overexpression in E.coli, MP is known to form ‘inclusion bodies’ (Citovsky et 
al., 1990; Brill et al., 2000). These dense protein aggregates are highly insoluble under 
native conditions, rendering them unsuitable for most common types of preparative 
biochemistry. Fortunately however, due to their high stability in the presence of salts 
and non-ionic detergents, inclusion bodies can be readily fractionated from the majority 
of cellular components by differential centrifugation. Furthermore, inclusion bodies 
can be fully solubilized under denaturing conditions, and while this results in only 
semi-pure preparations (80-90 % MP), MP prepared in this manner has been 
demonstrated to retain biological activity upon renaturation (Citovsky et al., 1990; 
Waigmann et al., 1994). It was therefore decided that inclusion body fractionation 
would be used as a starting point in the purification of MP from E.coli. 
2.1.1.2 Principle of Immobilized Metal Affinity Chromatography (IMAC) 
IMAC is a group-specific method for affinity purification of proteins and is based on 
the reversible interaction of amino acid side groups with divalent metal cations (Porath 
et al., 1975). Typically, a metal chelator, such as Nitrilotriacetic acid (NTA), is 
conjugated to a solid matrix where it also occupies 4 of the 6 available binding 
coordinates of Ni2+ or Co2+. The remaining coordinates interact strongly with histidine 
side groups, particularly when found in tandem repeats of 4–6 residues. Proteins 
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containing polyhistidine runs (“His-tagged proteins”) are able to interact with metal 
ions even in the presence of micelle concentrations of non-ionic detergents, high salt 
concentrations (> 4 M) and chemical denaturants such as 8 M Urea or 6M GuHCl. It 
was due to these advantageous properties of IMAC resins that we constructed a MP 
directly fused to 6 consecutive histidine residues, thereby allowing us to further purify 
MP isolated from inclusion bodies under both denaturing and high stringency 
conditions. 
2.1.1.3 General note about MP purification 
Although many His-tagged proteins have been successfully purified from crude cellular 
extracts (Schmies et al., 2000; Ferguson and Goodrich, 2001; Nunez et al., 2001), a 
common problem found is that C-terminally tagged proteins often co-purify with 
truncated, immunologically related products. This is thought to be due to imperfect 
initiation of translation occurring at methionine codons within the open reading frame, 
and in the case of MP, the degree to which these truncated products occur appears to 
vary between preparations. To counter this phenomenon, a number of variations in 
bacterial growth conditions and purification procedures were applied which included 
ion exchange-, immuno affinity- and size exclusion-chromatography, respectively. It 
must be noted, however, that MP purification solely by means of inclusion body 
isolation and Ni2+-NTA IMAC yielded the most favourable results, and unless 
otherwise stated in the text, all preparations of MP:(H)6 used for in vitro assays were 
prepared by this method and are thus simply referred to as “MP”. 
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2.1.2 Construction of plasmids for MP overexpression 
2.1.2.1 Overview of the QIAexpressä vector pQE60  
The commercial vector pQE60 (Qiagen) is designed for high level expression of 
proteins in E.coli which are fused to a C-terminal GS(H)6 affinity tag. Genes of interest 
may be cloned into an NcoI restriction site, allowing the restoration of an ‘in-frame’ 5’ 
ATG start codon. Expression is under the control of a strong T5 promoter located 
upstream of two Lac operator regions and a Shine-Dalgarno sequence. During normal 
growth, expression is repressed by high levels of the LacIq gene product which is 
constitutively supplied in trans from the pREP4 repressor plasmid present in 
commercial E.coli strain M15 (Qiagen; derived from E.coli strain K12). A stop codon 
and two transcription terminator sequences directly downstream of the multiple cloning 
site facilitate precise termination of protein translation and prevent read-through of 
transcription. Plasmids pQE60 and pREP4 confer ampicillin and kanamycin resistance, 
respectively, and efficient induction of expression is achieved by applying IPTG to the 
growth media. 
2.1.2.2 Cloning procedures 
Standard molecular biology techniques were employed during the production of MP-
expression constructs and are essentially as described (Sambrook and Russell, 2001). 
Plasmid pTf5-NX2 (Boyko et al., 2002) was utilized as a template for PCR-
amplification of the MP gene. Primers containing specific sequence mismatches (see 
Appendix II) were used to introduce unique 5’ Eco47III and 3’ BamHI restriction sites 
into the MP sequence during PCR. Resulting products were digested with Eco47III 
followed by BamHI and full-length products were purified from 1 % agarose gels 
(QIAquick gel extraction kit, Qiagen) and quantified by measuring the absorbance at 
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260 nm. Expression vector pQE60 was digested with NcoI and treated with Klenow 
fragment, thereby filling in the 5’-overhang and creating a blunt end compatible with 
the Eco47III digested PCR product. The vector was further digested with BamHI, gel 
purified and quantified. Insert was ligated to vector (at a molar ratio of 3:1) using T4 
DNA ligase, according to the manufacturers recommendations and competent E.coli 
strain M15 (Qiagen) was directly transformed with ligation mixture and grown 
overnight at  37 oC on LB-Agar containing 50 mg/mL of carbenicillin and 25 mg/mL of 
kanamycin. The integrity of the resulting expression vector (designated pQTf5-WT) 
was determined by plasmid DNA extraction and DNA sequence analysis. Positive 
expression clones contained a restored 5’ ATG start codon and coding sequence of MP, 
with a 3’-proximal sequence coding for -GS(H)6 directly adjacent to a downstream 
TAA stop codon.  
2.1.3 Overexpression of MP 
A single bacterial colony was used to inoculate 20 mL of 2X YT media containing 50 
mg/mL of carbenicillin and 25 mg/mL of kanamycin. Overnight cultures were 
subsequently grown at 37 oC with agitation (230 rpm). Large-scale cultures were 
prepared by inoculating 400 mL of the above media with 10 mL of overnight culture 
and were grown under the described conditions until OD600 reached ~ 0.8 (typically 3 
hours). MP overexpression was initiated by the addition of 2 mM of IPTG and cultures 
were further grown for 3 hours as described, after which, cells were harvested by 
centrifugation at 10,000 x g in a Sorvall GSA rotor for 10 mins at 4 oC. 
2.1.4 Isolation of MP-containing inclusion bodies 
Cell pellets were resuspended in 15 mL of ice cold lysis buffer (20 mM Tris-CL [pH 
8.0], 30 U DNase I, 10 mg/mL RNase A and protease inhibitor cocktail [Promega]), 
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frozen in liquid nitrogen and thawed on water-slush. Lysates were repeatedly sonicated 
(50 W) on ice (Labsonic 2000; B. Braun, Melsungen, Germany) and insoluble 
inclusion bodies were collected by centrifugation at 13,000 x g in a Sorvall SS34 rotor 
for 15 minutes at 4 oC. Inclusion bodies containing MP were washed by sonication in 
10 mL of ice cold inclusion body wash buffer (20 mM Tris-CL [pH 8.0], 2 M Urea, 500 
mM NaCl, 10 mg/mL RNase A, 2 % (v/v) Triton X-100 and protease inhibitor cocktail) 
followed by resedimentation at 25,000 x g in a Sorvall SS34 rotor for 10 minutes at 4 
oC. Inclusion bodies were repeatedly washed in this manner until a sediment of 
consistent colour was obtained (typically 3 times). Inclusion bodies were then 
solubilized by sonication in 5 mL of ice cold solubilization buffer (100 mM NaH2PO4 
[pH 7.5], 1 M NaCl, 10 mM Tris base, 8 M Urea and 10 % [v/v] Glycerol) containing 5 
mM Imidazole (SB5), followed by incubation on a rotary mixer overnight at  4 oC. 
Protein suspensions were cleared of insoluble material by centrifugation at 15,000 x g 
in a Sorvall SS34 rotor at 4 oC prior to further purification steps. 
2.1.5 Ni 2+-NTA Affinity Chromatography 
The cleared protein suspensions were combined with 2.5 mL of Ni2+-NTA sepharose 
(Qiagen) by platform shaking for 30 minutes at 4 oC, after which time, the resin and 
lysates were packed into disposable 1 cm diameter plastic columns (Bio-Rad 
Laboratories) and the resin allowed to settle. Columns were drained by gravity flow 
and the Flow-through fractions were collected for later analysis. Non-specifically 
bound proteins were subsequently removed by washing the columns twice with 5 
column volumes of SB5 (Wash Fractions I and II) followed by twice with 8 column 
volumes of SB20 (Wash fractions III and IV). Elution was achieved by gently layering 
10 volumes of SB500 onto the top of the resin bed and allowing the buffer to drain 
through by gravity flow, while collecting 500 mL fractions (Elution fractions I–VIII). 
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As determined by SDS-PAGE and Colloidal Coomassie Blue (CCB) staining, residual 
non-specifically bound proteins co-eluted with MP in the early elution fractions (EI-
IV), while highly purified MP eluted in subsequent fractions, albeit in lower quantities. 
2.1.6 Renaturation of purified MP 
Elution fractions containing the highest apparent MP purity were renatured by direct 
dialysis against 50 mL of deionized water (dH2O) for 30 minutes at room temperature 
and then twice against 4 L of dH20 for several hours at 4 oC. Proteins were cleared of 
aggregated material by centrifugation at 20,000 x g for 30 min (4°C) in a desktop 
microcentrifuge, followed by centrifugation at 100,000 x g for 1 hour in a Beckman 
TLA-100.3 rotor at 4°C. A protein concentration assay was performed (Bradford, 
1976) and solutions were diluted to 0.1 – 0.5 mg/mL (~ 3–15 mM) with dH2O before 
being rapidly frozen in liquid nitrogen and stored at –80 oC. When specific buffering 
was required, MP was rapidly thawed at 30 oC and immediately placed on ice before 
the appropriate buffer components were added to the desired concentration. To control 
for variations in buffer-induced aggregation, MP was then incubated for at least 30 
minutes on ice and centrifuged for 15 minutes at 100,000 x g in a Beckman TLA-100 
ultracentrifuge at 4°C before being assayed for protein concentration as above. This 
procedure was performed after every aliquot thaw/buffer addition.  
2.1.7 Determination of final MP purity by Mass Spectrometry 
MP was purified and renatured as above and 10 mg of protein was visually analyzed by 
12 % SDS-PAGE and CCB staining. Under sterile conditions, the 30 kDa MP band 
was excised from the gel, reduced with 2 % (w/v) DTT, alkylated with 5 % (w/v) 
iodoacetamide before the protein was digested overnight at 37 oC with protease Lys-C 
in 50 mM ammonium bicarbonate buffer, pH 8.0 (Shevchenko et al., 1996). The 
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extracted peptides were analyzed by capillary liquid chromatography tandem mass 
spectrometry (LC-MSMS) using a Magic C18 100 µm x 10 cm HPLC column 
(Spectronex, Switzerland) connected online to a Finnigan DecaXP iontrap 
(ThermoFinnigan, CA). A linear gradient from 5% to 50% (v/v) of buffer B (0.1% 
Formic Acid, 80% Acetonitril in H2O; diluted with 0.1% Formic Acid, 2% Acetonitril 
in H2O) was delivered with a Rheos 2000 HPLC system (Flux, Switzerland) at 100 
µl/min over 60 minutes. A precolumn flow splitter reduced the flow to approximately 
300 nl/min and the peptides were manually loaded with a 10 µl Hamilton syringe on a 
peptide captrap (Michrom BioResources, Inc, CA) mounted in the injection loop of the 
Mass Spectrometer (MS). The eluting peptides were ionized by electrospray ionization, 
detected, and the individual ionized peptides were automatically selected and 
fragmented further in the iontrap. Subsequent MSMS spectra, containing sequence 
information for the corresponding single peptides, were analyzed in silico using the 
program TurboSequest versus a customized database containing the known sequence of 
MP (Goelet et al., 1982). Peptide sequences that were not automatically attributable to 
MP were manually analyzed, taking into account variations in amino acid oxidation 
and/or acetylation. Peptide sequences not assigned by this method were considered to 
be non-lysine cleavage products, the result of alternative chemical modifications or of 
foreign origin. 
2.2 In vitro RNA binding assays 
2.2.1 RNA band-shift assay using a short 32P-labeled probe 
This method was established to verify the RNA binding activity of our MP 
preparations using a method comparable to those previously described for MP in the 
literature. A 123 nucleotide [g-32P]UTP-labeled RNA was produced by in vitro 
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transcription (MAXIscript T7 kit; Ambion Inc.) using a PCR-derived DNA template 
corresponding to the 5’-terminal region of the GFP gene containing a synthetic 5’-
proximal T7 promoter sequence. Transcripts were purified by 6% denaturing PAGE 
(Stern and Gruissem, 1987) and resuspended in dH2O (specific activity, 1.1 x 107 
cpm/mg of RNA). The in vitro RNA-binding assay was performed by incubation of 10 
nM (~ 4.4 ng) of RNA probe with increasing amounts of MP (pre-equilibrated with 10 
mM Tris-Cl [pH 7.5]) for 30 min at 4 °C in a 10 mL reaction mixture containing 10 
mM Tris-Cl, pH 7.5, and 0.1% (v/v) Triton X-100. Samples were then loaded onto 1% 
non-denaturing agarose gels (in 45 mM Tris-borate [pH 8.0] and 0.1% [vol/vol] Triton 
X-100) and electrophoresed for 2 hours at 6.5 V/cm. Gels were dried at 80 °C and 
exposed to X-ray film for 3 hours at -75°C. 
2.2.2 Modified conditions suitable for TMV-derived RNA 
A 6.7 kb TMV-derived RNA was produced by in vitro transcription (MEGAscript T7 
kit, Ambion Inc.) using Acc65I-linearized plasmid pTf5-WT as a template. Following 
transcription, template DNA was digested with 2U of DNase I for 15 minutes at 37 oC 
and RNA was purified by extraction with a mixture of acid-buffered Phenol (pH 5.5), 
Chloroform and Isoamylalchohol (25:24:1 v/v) followed by gel filtration (Microspinä 
G-25 column, Amersham Biosciences) into RNase-free H2O. RNA was quantified by 
measuring the absorbance at 260 nm and binding assays were performed by incubating 
10 nM (625 ng) of RNA with increasing amounts of MP for 15 minutes at 4 oC in a 
reaction mixture (20 mL) containing 10 mM Tris-Cl (pH 7.5) and 1 mM DTT. In 
control reactions, BSA (in 10 mM Tris-Cl, pH 7.5) was substituted for MP. Samples 
were loaded onto a 1% non-denaturing agarose gel (in 40 mM Tris-acetate and 1 mM 
EDTA) containing 0.1 mg/mL ethidium bromide and were electrophoresed at 12.5 
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V/cm for 45 minutes. Gels were recorded using an EagleEye II UV transluminator 
(Stratagene, Ca). 
2.3 Infection of BY-2 protoplasts and Nicotiana benthamiana 
with mutant TMV-derivatives encoding –(H)6 affinity tags 
It was reasonably suggested that the presence of a –(H)6 affinity tag might be 
detrimental to MP function during viral infection. To address this question, TMV 
derivatives were produced that lacked the coat protein (CP) ORF and encoded either 
MP:GFP, MP:(H)6:GFP or MP:GFP:(H)6. Tobacco BY-2 protoplasts and Nicotiana 
benthamiana leaf epidermal cells were subsequently infected with in vitro transcribed 
infectious RNA derived from these viral constructs. 
2.3.1 Construction of TMV derivatives 
2.3.1.1 TMV-MP:(H)6:GFP 
Plasmid pTf5-NX2 (Boyko et al., 2002) was digested with BlnI for 3 hours at 37 oC, 
and linearized DNA was purified (QIAquick PCR purification kit, Qiagen) and 
subsequently digested with SalI for 3 hours at 37 oC. To prevent self-ligation of the 
linearized plasmid DNA, the 5’-phosphate groups were removed with 10 units of calf 
intestinal alkaline phosphatase (CIAP) directly added to the restriction reaction for 15 
minutes at 37 oC. The resulting 9.5 kb plasmid DNA was excised from a 1 % agarose 
gel, purified (QIAquick gel extraction kit, Qiagen) and quantified by measuring 
absorbance at 260 nm. To produce the DNA insert coding for -GS(H)6, two 
complementary oligonucleotides (see Appendix II), were synthesized (Microsynth, 
Switzerland), desalted (Microspinä G-25 column, Amersham Biosciences) and the 
oligonucleotides (6 mM) were individually phosphorylated with 10 units of T4 
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Polynucleotide Kinase (PNK) in the supplied reaction buffer for 30 minutes at 37 oC. 
The combined oligonucleotides were annealed by heating to 75 oC and slowly cooling 
to room temperature. The resulting dsDNA insert containing 5’ SalI and 3’ BlnI 
compatible cohesive ends, was ligated to the prepared plasmid DNA at a molar ratio of 
10:1, respectively, using T4 DNA ligase. Cells of the E.coli strain DH5a were 
transformed with 10 mL of ligation mixture and constructs containing the desired insert 
were verified by DNA sequence analysis. Positive constructs were modified (red) 
within the hinge region between MP and GFP (blue) to encode the following protein 
sequence: MP-PVVDGS(H)6LGPGIS(G)5ILDLK-GFP. 
2.3.1.2 TMV-MP:GFP:(H)6 
Using a similar approach, a dsDNA (see Appendix) coding for -R(H)6 and containing 
cohesive ends compatible with NotI/XhoI digested Tf5-NX2 was prepared and ligated 
to vector as described. Positive constructs were identified by DNA sequence analysis 
and encoded: MP:GFP-(H)6, with a single amino acid deletion from the C-terminus of 
GFP. 
2.3.2 Preparation of BY-2 protoplasts and transfection with viral 
RNA derived from “His-tagged” TMV constructs 
RNA transcripts corresponding to TMV (+) sense strands were produced by in vitro 
transcription (MEGAscript T7 kit, Ambion Inc.), using Acc65I digested plasmids pTf5-
MP:GFP (NSPAX), pTf5-MP:(H)6:GFP or pTf5-MP:GFP:(H)6 as templates, in 
reactions containing CAP analogue (m7G(5')ppp(5')G, Ambion Inc.). No further RNA 
purification was required prior to protoplast transfections. To produce BY-2 
protoplasts, 50 mL of tobacco BY-2 suspension cell culture was centrifuged in a Sigma 
3K10 swing-bucket centrifuge for 1 minute at 600 rpm (~ 65 x g) at 20 oC and cells 
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were resuspended in 40 mL 0.4 M D-mannitol and allowed to plasmolyse for 10 
minutes at room temperature. Cells were sedimented for an additional minute as above 
and were resuspended in 15 mL of enzyme solution (1 % w/v cellulase Onozuka RS 
and 0.1 % w/v pectolyase Y23, in 0.4 M D-mannitol) and incubated in a petri dish for 3 
hours at 28 oC with occasional agitation. Following digestion, cells were washed twice 
with 40 mL 0.4 M D-mannitol and aliquots containing approximately 2 x 106 
protoplasts (1-2 ml) were transferred into sterile 10 mL tubes and pelleted as above. 
Pellets were resuspended in 600 mL electroporation buffer (0.3 M D-mannitol, 70 mM 
KCl, 5 mM MES pH 5.8) and were mixed with viral RNA transcripts (~ 40 mg in 200 
mL electroporation buffer) in a 0.4 cm gap electroporation cuvette (Bio-Rad 
Laboratories). Protoplasts were transfected by electroporation using the Bio-Rad gene 
pulser II, applying infinite resistance (4) at a capacity of 125 mF, and a pulse of 0.3 kV 
for ideally 4.5-5.2 ms. The protoplasts were immediately transferred to 10 mL tubes 
and incubated on ice for 30 minutes, and subsequently, room temperature for 5 
minutes. Then, 10 mL of protoplast culture medium (2.2 mg/mL MS salts, 1 mg/mL 
Thiamine-CL, 0.1 mg/mL myoinositol, 10 mg/mL sucrose, 0.2 mg/mL 2,4-
dichlorophenol acetic acid [pH 5.8] and 400 mM D-mannitol) was added. Aliquots of 
protoplasts (1 mL) were cultured at 28 oC in the presence of 10 mg/mL actinomycin-D 
for 18 hours. 
2.3.3 Infection of Nicotiana benthamiana with viral RNA transcripts 
derived from “His-tagged” TMV constructs 
N. benthamiana plants were grown from seed under conditions of 70 % humidity and 
temperature of 22 oC during the 16 hour photoperiod and 20 oC during the dark period. 
Expanded leaves of 5 week old plants were mechanically inoculated (in the presence of 
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carborundum) with RNA transcripts prepared as described (Materials and Methods 
section 2.3.3) and plants were grown for a further 3 days according to the above growth 
regime. 
2.3.4 Analysis of infection sites 
Infected leaves were illuminated with a BLAK RAY B-100AP UV lamp (UVP Inc., 
Upland, Ca) and images were captured using a Canon EOS-D30 digital camera 
equipped with Canon EF 100 mm 1:2.8 macro lens. Images were imported into Adobe 
Photoshop 6.0.1 software (Adobe Systems Incorp.) before the total number of pixels 
and mean pixel intensity within each respective infection site were determined using 
the built-in histogram function. Values obtained from at least two infected leaves were 
averaged and pixel intensities corresponding to non-infected leaf tissue (30 readings 
per leaf) were used for background corrections. Equivalent metric units for area were 
calculated according to the known pixel:area ratio obtained from a calibration image. 
2.3.5 Subcellular localization of MP 
Following culturing at 28 oC for 18 hours, transfected protoplasts (0.5-1 mL) were 
chemically fixed with an equal volume of protoplast fixative (6 % [w/v] 
paraformaldehyde and 10 mM EGTA in PBS [pH 7.4]) for 30 minutes at room 
temperature. Cells were pelleted by centrifugation at 800 rpm in a Sigma 3K10 swing-
bucket centrifuge for 4 minutes at room temperature and resuspended in 150 mL of the 
resulting supernatant. Samples were spun onto Poly-L-Lysine coated glass slides in a 
Shandon Cytospin 3 for 2 minutes at 2000 x g and dried overnight at 4 oC in the dark. 
For immunohistochemical labeling of tubulin, samples were washed with PBS (pH 7.4) 
containing 0.5 % (v/v) Tween-20 and 10 mM EGTA (PBST-E) for 10 minutes at room 
temperature, and the cells were then permeabilized with cold methanol (-20 oC) for 10 
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minutes followed by two washing steps with PBST, each for 10 minutes. Monoclonal 
anti-a-tubulin antibody (DM1A; EMD Biosciences Inc., Germany) was applied to 
samples (1:500 dilution) under humid conditions for 1.5 hours at room temperature. 
Slides were washed six times at room temperature with a large volume of PBS before 
tetra-rhodamine isothiocyanate TRITC-conjugated secondary anti-mouse IgG antibody 
(1:100; Pierce Biotechnology) was applied and the samples were incubated for 1 hour 
at room temperature in a darkened humid chamber. After samples were washed as 
above and briefly rinsed with dH2O, glass coverslips were mounted onto a drop of 
Mowiol (Calbiochem) containing 2.5 % 1,4-diazobicyclo-[2.2.2.]-octane (DABCO) as 
an antifade agent. Detached N. benthamiana leaves containing fluorescent infection 
sites were directly placed on glass slides and viewed under oil using a 60 X objective 
lens. Fluorescence microscopy was carried out on a Nikon Eclipse E800 microscope 
equipped with Plan Apochromat objective lenses (Nikon). For specific visualization of 
GFP and TRITC fluorescence, DM505 (Nikon) and G-2A (Nikon) filter sets were used, 
respectively. Images were acquired and processed using an ORCA-100 progressive 
scan interline charge-coupled-device camera (Hamamatsu Photonics, Hamamatsu City, 
Japan) and Openlab 3.1 software (Improvision, Coventry, England). 
2.4 In vitro Microtubule-associated protein (MAP) assay  
2.4.1 Principle of the MAP assay 
A relatively simple in vitro method to test whether a protein can interact with 
microtubules is cosedimentation (Ackmann et al., 2000). This approach relies on the 
fact that purified tubulin dimers can be polymerized in vitro to form true microtubules 
with typically 12-15 protofilaments (Bohm et al., 1984; Chretien et al., 1992) and 
lengths varying between 2-40 mm (Farrell et al., 1987). Due to the large size of these 
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structures (at least 400 MDa/mm), MTs and associated proteins can be sedimented by 
centrifugation, leaving soluble non-binding proteins and unpolymerized tubulin in the 
supernatant. The protein content of each fraction can then be quantified by SDS-PAGE 
and scanning gel densitometry. If one allows a steady-state in the binding reaction to be 
achieved and also assumes independent binding sites on the MT surface, this 
interaction can be viewed as classical receptor-ligand equilibrium binding (Klotz, 
1946; Scatchard, 1949; Hulme and Birdsall, 1991). Therefore, when the concentration 
of polymerized tubulin (receptor) is kept constant and the binding protein (ligand) is 
titrated over 3 orders of magnitude, [ligand]bound can be plotted versus. [ligand]free, 
yielding a saturation hyberbole according to the Langmuir equation (see Appendix III 
for derivation of this, and related equations). The binding stoichiometry (n) and 
dissociation constant (Kd) of the ligand can then be solved by non-linear regression 
analysis.  
2.4.2 Determination of appropriate reaction conditions 
Initial attempts to perform the MAP assay demonstrated that MP non-specifically 
aggregated in the standard published reaction buffer BRB80 (80 mM Pipes-OH [pH 
6.8], 1 mM MgCl2 and 1 mM EGTA) containing 1 mM GTP. To overcome this 
problem, the solubility of MP was systematically tested in the presence of each of the 
buffer constituents and combinations thereof. Since a fixed MT concentration is also a 
requisite for quantitative analysis of binding, conditions that support MT stability were 
tested in a similar manner. 
2.4.2.1 MP solubility assay 
Frozen aliquots of MP in dH2O were rapidly thawed at 30 oC and immediately 
centrifuged at 20,800 x g for 20 minutes (4 oC) in an Eppendorf 5417C desktop 
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microcentrifuge and placed on ice. Respective buffer components (summarized in 
Table 2) were mixed in 1.5 mL eppendorf tubes at room temperature. Approximately 7 
mg of MP was then added to the buffer mixtures (final volume 30 mL), briefly vortexed 
and incubated at room temperature for 1 hour. Mixtures were centrifuged for 30 
minutes at 20,800 x g in a Sorvall 5404 microcentrifuge (room temperature) and the 
supernatants were transferred to fresh eppendorf tubes. Pellets were resuspended in 30 
mL of 10 mM Tris-Cl (pH 6.8) and both fractions were analyzed by SDS-PAGE and 
CCB staining. When 95 % or more of the MP remained in the supernatant, the protein 
was considered soluble. In all cases where MP was insoluble, no MP could be detected 
in the supernatant fraction. 
2.4.2.2 Microtubule stability assay 
Tubulin heterodimers (5 mg/mL) purified from bovine brain (Cytoskeleton Inc.) were 
thawed on ice and polymerized in buffer BRB80 containing 1 mM GTP for 45 minutes 
at 37 oC in a 10 mL reaction. To suppress the microtubule dynamics, taxol (Paclitaxel, 
Sigma) dissolved in anhydrous DMSO was added to a final concentration of 50 mM in 
three steps with 10 minute incubations at 37 oC in-between additions. Microtubules 
were further stabilized by incubation at room temperature for at least 12 hours. To 
remove unpolymerized tubulin, 90 mL of BRB80 containing 25 mM Taxol was added 
and the microtubules were sedimented at 20,800 x g in an Eppendorf 5417C 
microcentrifuge at room temperature. Aspirated supernatants were discarded and 
microtubules were resuspended in 60 mL of the test buffer without GTP, by gentle 
pipetting, and were incubated for 30 minutes at room temperature. Polymerized and 
depolymerized tubulin was separated by centrifugation at 20,800 x g for 30 minutes at 
room temperature and supernatants were transferred to fresh tubes. Pellets were 
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resuspended in 60 mL of 10 mM Tris-Cl (pH 6.8) and both fractions were analyzed by 
SDS-PAGE and CCB staining. 
2.4.3 MAP assay  
Microtubules were polymerized as above with the following modifications. To ensure 
the removal of free GTP from the buffer, stabilized MTs were washed twice by 
sedimentation and resuspension in BRB80 containing 25 mM Taxol as described. Final 
pellets were resuspended in 25 mL of MAP binding buffer (12 mM Pipes-OH [pH 
6.85], 0.5 mM MgCl2, 10 % [v/v] Glycerol, 0.01 % [v/v] Tween-20 and 10 mM Taxol) 
and a 5 mL aliquot was removed, heat-denatured at 80 oC for 5 minutes and measured 
for protein concentration by the method of Bradford (Bradford, 1976). MP in dH2O 
was rapidly thawed at 30 oC, incubated on ice for 30 minutes and cleared of non-
specific aggregates by centrifugation at 100,000 x g for 15 minutes in a Beckman TLA-
100 ultracentrifuge at 4°C. An aliquot of the MP was removed and measured for 
protein concentration. Binding reactions (25 mL) were performed by incubating 1-3 mM 
polymerized tubulin with up to 10 mM MP in MAP binding buffer for 10 minutes at 
room temperature. MTs and associated MP were pelleted by centrifugation at 20,800 x 
g for 10 minutes in an Eppendorf 5417C centrifuge at room temperature and 
supernatants were transferred to fresh tubes. Pellets were resuspended in 25 mL of 10 
mM Tris-Cl (pH 6.8) and both fractions were analyzed by SDS-PAGE and CCB 
staining. To control for non-specific aggregation effects, aliquots of the MP stock (0.1-
10 mM) were treated in the same manner without MTs, and analyzed by SDS-PAGE 
and CCB staining. Each binding reaction was performed at least three times, and for 
the lowest concentrations of MP (0.1-3 mM), reactions volumes were scaled-up to 
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better facilitate protein detection on CCB stained gels. For downstream quantification, 
0.1-20 mM MP was analyzed directly by SDS-PAGE and CCB staining. 
2.4.4 Control reactions to determine the effect of –(H)6 on MT 
binding in vitro 
MP and MTs were prepared as described for the MAP assay. Binding reactions (50 mL) 
were assembled in MAP binding buffer containing 1.5 mM of either; GST-(H)6 (kindly 
donated by A. Furmanek, FMI, Basel), recombinant (H)6-Tau 441 (Panvera), BSA 
(Pierce Biotechnology) or MP, respectively. Samples were incubated in the presence or 
absence of 6 mM polymerized tubulin at room temperature for 30 minutes and MTs 
together with associated proteins were sedimented by centrifugation at 20,800 x g in an 
Eppendorf 5417C centrifuge for 10 minutes at room temperature. Supernatants were 
discarded and the pellets were resuspended in 30 mL of 10 mM Tris-Cl (pH 6.8) and 
analyzed by SDS-PAGE and CCB staining. To visually compare the protein amounts, 
1.5 mM of each respective protein was analyzed on the same SDS-PAGE gel without 
prior treatment. 
2.4.5 Analysis of Microtubule binding by MP in vitro 
CCB stained SDS-PAGE gels were digitized using a Typhoon 9400 variable mode 
imager (Amersham Biosciences) and images were imported into Scion Image beta 4.01 
densitometry software (Scion corporation). A standard curve of known MP amounts 
was produced by measuring the average pixel intensity (arbitrary units) within a fixed 
area containing protein bands of MP (0.1-20 mM). The mean pixel intensity of at least 
10 background readings was subtracted from these values which were subsequently 
plotted against the corresponding original MP concentration, yielding a straight line (r2 
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= 0.995). MP amounts on sample gels were estimated by measuring the mean pixel 
intensity (minus gel background) and reading the mM equivalent from the standard 
curve. It should be noted that differences in gel staining resulted in variable values for 
[MP], therefore, to validate these data, the apparent [MP]bound and [MP]free 
concentrations were summed and plotted against the theoretical starting concentration. 
Only data sets producing a straight line relationship (termed ‘internal standard’) were 
considered for further analysis. From control gels, the amount of non-specifically 
pelleted MP was quantified using the above approach and final values for [MP]bound 
and [MP]free were adjusted accordingly (typically < 5% difference). Binding data where 
were produced by plotting values for [MP]bound versus [MP]free and fitting a curve to 
these data according to either a one-site (Appendix III eq. 11) or two-site (Appendix III 
eq. 12) equilibrium binding model, as detailed below: 
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Where v  is the fraction of all MP binding sites on tubulin, n is the total number 
equivalent MP binding sites, [L] is the relative concentration of unbound MP and Kd is 
the binding dissociation constant of MP  
 
Values for binding stoichiometry (n), dissociation constant (Kd) and relative strength of 
curve fitting (r2) were calculated using the built-in non-linear regression analysis 
function. To discriminate between the most appropriate binding model, the fits of each 
respective curve were compared by one-way analysis of variance (ANOVA), assuming 
a null hypothesis that a one-site model is correct (Motulsky and Christopoulos, 2003). 
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For outputs of the regression analyses and ANOVA calculations, please refer to 
Appendix III. Scatchard-Rosenthal plots (Scatchard, 1949; Rosenthal, 1967) were 
produced by plotting [MP]bound/[MP]free versus [MP]bound and fitting a 3 parameter 
rational term to the data (y = a+b/1+cx) using a best-fit trial and error approach. 
2.5 Visualization of MP:MT complexes formed in vitro 
Initial attempts to visualize MP:MT complexes formed in vitro by antibody labeling 
and fluorescence microscopy demonstrated that without fixation, such complexes were 
unstable over the course of the labeling procedure. Additionally, when the complexes 
were chemically fixed in free solution prior to labeling, extensive MT-bundling and 
artefactual MP-aggregation became readily apparent. Therefore, a perfusion chamber 
system was established which allowed MTs to be immobilized on glass slides by virtue 
of the molecular motor protein kinesin. Complexes formed in the perfusion chamber 
could then be manipulated in such a way as to preclude formation of the 
aforementioned artefacts while still facilitating immunohistochemical labeling and 
fluorescence microscopy. 
2.5.1 Immobilization of MTs in kinesin coated perfusion chambers 
Perfusion chambers were produced by placing two 50 mm strips of scotch tape 
lengthways along a plain glass slide with a gap of 6 mm between each strip. An 18 mm 
square glass coverslip was then attached to the tape strips using transparent nail 
varnish. The resulting chambers had a volume capacity of 8 ± 2 mL, and buffers could 
be perfused through the chamber by pipetting buffer into one side and simultaneously 
removing buffer from the other using Whatman paper as an absorbent wick. Rates of 
buffer exchange were typically in the range of 5-10 mL per second, however, pilot 
experiments using an aqueous dye (bromophenol blue) showed that buffer flow was not 
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laminar along the edges, and therefore, subsequent microscopic analyses were made at 
the centre of the chamber in order to attain experimental consistency. Human 
(recombinant) GST-conjugated kinesin-1 heavy chain (amino acids 1-379; 
Cytoskeleton Inc.) was applied to the chamber (1.7 mg/mL [12 nM]) in kinesin binding 
buffer (BRB80 containing 1 mM DTT, 10 mM Taxol and 0.25 mg/mL casein) and 
incubated at room temperature for 5 minutes. Unbound proteins were washed out with 
approximately 5 chamber volumes (50 mL) of kinesin wash buffer (BRB80 containing 
1 mM DTT, 10 mM Taxol and 0.1% BSA) at room temperature. Prepared chambers 
could then be stored under humid, darkened conditions for at least a week (4 oC) 
without significant loss of MT binding activity. Tubulin was polymerized as described 
in Materials and Methods section 2.4.2.2 and diluted with kinesin wash buffer (~ 90 
nM tubulin dimer) before 5 volumes were perfused through the chamber and incubated 
for 5 minutes at room temperature. Unabsorbed MTs were washed out with 7.5 
volumes of MAP binding buffer (12 mM Pipes-OH [pH 6.85], 0.5 mM MgCl2, 10 % 
[v/v] Glycerol, 0.01 % [v/v] Tween-20 and 10 mM Taxol). At this stage the chambers 
could be stored under darkened, humid conditions at room temperature for up to an 
hour.  
2.5.2 Formation and visualization of MP:MT complexes 
MP in dH2O was rapidly thawed and diluted to 0.1-5 mM with MAP binding buffer (12 
mM Pipes-OH [pH 6.85], 0.5 mM MgCl2, 10 % [v/v] Glycerol, 0.01 % [v/v] Tween-20 
and 10 mM Taxol) before being cleared of aggregated material for 15 minutes at 
100,000 x g in a Beckman TLA 100.3 rotor at 4 oC. Five chamber volumes of MP 
solution (10 nM – 5 mM) were perfused into the chamber and incubated at room 
temperature for between 1 and 30 minutes. Unbound MP was removed with 10 
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volumes of MAP binding buffer before proteins were fixed for 10 minutes at room 
temperature with 1% (v/v) gluteraldehyde in MAP binding buffer. Intact chambers were 
immediately immersed in PBS containing 0.5 % (v/v) Tween-20 (PBS-T). The 
chambers were disassembled and the slides containing bound proteins were dried for 1 
hour at room temperature. All subsequent steps were performed at room temperature. 
Free aldehydes were quenched twice for 10 minutes with a large volume of 0.1 % (w/v) 
NaBH4 in PBS-T and samples were further washed for 10 minutes with PBS-T. For 
immunohistochemical labeling, either rat monoclonal anti-a-tubulin antibody (YOL-
1/34; Camon Labor Service, Wiesbaden, Germany) was used in combination with a 
rabbit polyclonal antibody reactive against the N-terminus of MP (anti-MP-N; residues 
6-22), or mouse monoclonal anti-a-tubulin antibody (DM1A; EMD Biosciences Inc., 
Darmstadt, Germany) was used in combination with anti-MP-C (MP residues 209-
222), respectively. Primary antibodies were applied to samples (1:200 dilution in PBS-
T) and incubated for 1.5 hours before the slides were washed three times with a large 
volume of PBS-T. FITC-conjugated secondary anti-rabbit IgG antibody (1:100; Pierce 
Biotechnology) and either TRITC-conjugated secondary anti-rat IgG antibody (1:100; 
Jackson Immuno Research laboratories) or TRITC-conjugated secondary anti-mouse 
IgG antibody (1:100; Pierce Biotechnology) were applied to the samples and incubated 
for 1 hour under darkened conditions. Samples were washed five times with a large 
volume of PBS-T before glass coverslips were mounted onto a drop of Mowiol 
(Calbiochem), containing 2.5 % 1,4-diazobicyclo-[2.2.2.]-octane (DABCO) as an 
antifade agent. Fluorescence microscopy was carried out as previously described 
(Materials and Methods section 2.3.4) and final images were prepared using Adobe 
Photoshop 6.0.1 software (Adobe Systems Incorp.) 
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2.6  Co-precipitation experiments in vitro using immobilized 
MP as an affinity bait 
In an attempt to determine whether MP interacts specifically with binding contacts 
present on the surface of polymerized tubulin or can interact with unpolymerized 
tubulin dimers, a system was established whereby MP was immobilized on Ni2+-NTA-
conjugated sepharose beads and used as an affinity bait to co-precipitate free tubulin 
a/b heterodimers or polymerized tubulin in vitro. The effect of RNA on MP:tubulin 
binding was also investigated using a similar approach. 
2.6.1 Co-precipitation of MTs and tubulin heterodimers in vitro 
In order to reduce the likelihood of buffer induced MP-aggregation, 10 mL of bovine 
brain tubulin dimers (10 mg/mL; Cytoskeleton Inc.) and bovine serum albumin (BSA; 
2 mg/mL; Pierce Biotechnology) were dialysed overnight at 4 oC against 400 mL of 
pulldown buffer (40 mM Pipes-OH [pH 6.85], 0.5 mM MgCl2, 10 % [v/v] Glycerol, 
0.01 % [v/v] Tween-20 and 5 mM Imidazole). Microtubules were polymerized in vitro 
and exchanged into pulldown buffer containing 10 mM Taxol as described (Materials 
and Methods section 2.4.2.2) To ensure that MP bound the Ni2+-NTA affinity matrix 
by virtue of the  –(H)6 tag, 100 mL of MP (0.5 mg/mL in dH2O) was denatured with 1.4 
mL of solubilization buffer (SB) without imidazole (100 mM NaH2PO4, [pH 7.5], 1 M 
NaCl, 10 mM Tris base, 8 M Urea and 10 % (v/v) Glycerol) and was incubated 
overnight at  4 oC. Ni2+-NTA beads (30 mL of 50 % slurry; Qiagen) were equilibrated 
with 500 mL of SB, sedimented briefly at 20,800 x g (room temperature) using an 
Eppendorf 5417C desktop microcentrifuge and resuspended in 200 mL (~ 5 mg) of 
denatured MP solution. MP was allowed to bind the beads for 30 minutes at room 
temperature with gentle shaking before unbound protein was removed by sedimenting 
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the beads and aspirating the resulting supernatants. MP was refolded on the beads by 
resuspending the pellets in 500 mL of pulldown buffer and incubating for at least 1 hour 
at 4 oC, with gentle shaking. Beads were again pelleted and the supernatants discarded 
before binding reactions were set-up in the following way. To block non-specific 
binding sites, the beads were resuspended in 40 mL of BSA solution (8 mg in pulldown 
buffer) and incubated for 10 minutes at 4 oC. Tubulin (5 mg tubulin dimers or MTs in 
pulldown buffer containing 50 mM Taxol) was added to a final volume of 50 mL and 
incubated at 4 oC for 15 minutes before the beads were pelleted by centrifugation at 
20,800 x g for 1 minute in an Eppendorf 5417C desktop microcentrifuge at room 
temperature. Supernatants containing unbound material were carefully transferred to 
fresh 1.5 mL eppendorf tubes and the pellets containing bound proteins were washed 
five times by repeatedly pelleting/resuspending the beads in fresh pulldown buffer 
containing 10 mM Taxol (750 mL), with 10 minute incubations at 4 oC between each 
centrifugation. Bound proteins were eluted by incubating the beads for 30 minutes at 4 
oC in 50 mL of SB containing 500 mM Imidazole before fractions containing bound 
and unbound proteins (10 mL) were separated by 12 % SDS-PAGE and transferred to 
polyvinylidene diflouride membrane (Bio-Rad Laboratories). Membranes were probed 
with either anti-MP-C (reactive against MP residues 209-222) or anti-a-tubulin 
(DM1A) followed by peroxidase-conjugated secondary antibody (Pierce 
Biotechnology), and the presence of either protein was indirectly detected with 
Supersignalä West Dura substrate (Pierce Biotechnology) by exposure to X-ray film. 
To control for non-specific binding of tubulin to the sepharose beads, the above 
procedure was also performed using beads that were not conjugated to MP. 
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2.6.2 Co-precipitation of RNA and tubulin heterodimers in vitro 
A 6.7 kb TMV-derived RNA was produced by in vitro transcription (MEGAscript T7 
kit, Ambion Inc.) using Acc65I-linearized plasmid pTf5-MP:GFP:(H)6 as a template. 
Following transcription, template DNA was digested with 2U of DNase I for 15 
minutes at 37 oC and RNA was purified by extraction with a mixture of acid-buffered 
Phenol (pH 5.5), Chloroform and Isoamylalchohol (25:24:1 v/v) followed by gel 
filtration (Microspinä G-25 column, Amersham Biosciences) into RNase-free H2O. 
RNA was quantified by measuring the absorbance at 260 nm and verified by 1 % non-
denaturing agarose gel electrophoresis. All other reaction components were prepared as 
described in the preceding section. Following the conjugation and refolding of MP on 
Ni2+-NTA beads (5 mg MP or 3.25 mM final concentration), non-specific binding sites 
were blocked by incubating the beads for 10 minutes at 4 oC in 30 mL of pulldown 
buffer containing 10 mg of BSA. As summarized in Table 1, binding reactions (50 mL 
final volume) were then set-up using a two-step approach whereby equal volumes of 
either tubulin heterodimers (1.63 mM final concentration) or RNA (5 mg or 0.05 mM 
final concentration) were first added to the beads and incubated for 15 minutes at 4 oC. 
Following this, equal volumes of either tubulin, RNA or pulldown buffer were then 
added and incubated for a further 15 minutes at 4 oC. MP was omitted in reactions 5 
and 6 in order to control for non-specific binding of either tubulin or RNA to the 
sepharose beads. The beads were subsequently pelleted by centrifugation at 20,800 x g 
for 1 minute in an Eppendorf 5417C desktop microcentrifuge at 4 oC and the 
supernatants were collected. Pelleted beads were washed five times by repeatedly 
pelleting/resuspending the beads in ice-cold pulldown buffer containing 10 mM Taxol 
(400 mL), with 10 minute incubations on ice between each centrifugation. Bound 
components were eluted for 30 minutes at 4 oC with 70 mL of solubilization buffer 
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containing 500 mM Imidazole and 10 mL aliquots of each pellet fraction were analyzed 
by SDS-PAGE and Western blotting using antibodies specific against MP and a-
tubulin, respectively. RNA within the remaining eluents was repurified by gel filtration 
(Microspinä G-25 column, Amersham Biosciences) into RNase-free H2O and 
analyzed by 1 % non-denaturing agarose gel electrophoresis and UV-translumination. 
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Reaction 1 2 3 4 5* 6* 
 
First incubation 
Tubulin 10 mL 10 mL X X 10 mL 10 mL 
RNA X X 10 mL 10 mL X X 
 
Second incubation 
Tubulin X X 10 mL X X X 
RNA X 10 mL X X X 10 mL 
pulldown buffer 10 mL X X 10 mL 10 mL X 
 
(*) MP was omitted from these reactions.  
 
 
Table 1 Co-precipitation of RNA and tubulin heterodimers in vitro using 
immobilized MP as an affinity bait: summary of binding reactions performed 
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2.7 In vitro kinesin motility assays 
Perfusion chambers were fabricated as described in Materials and Methods section 
2.5.1 and were coated for 3 minutes at room temperature with 10 mL of casein (0.25 
mg/mL) and human GST-conjugated kinesin-1 heavy chain (50 mg/mL; Cytoskeleton 
Inc.) in motility buffer (50 mM Pipes-OH [pH 6.85], 1 mM EGTA, 2 mM MgCl2, 
2 mM ATP, 10 mM Taxol, 10 % [v/v] Glycerol and 150 mM KCl). In order to reduce 
oxidative damage to proteins, unbound material was removed with 50 mL of motility 
buffer containing an oxygen scavenger system (motility buffer+OS) consisting of 18 
mg/mL catalase, 0.1 mg/mL glucose oxidase, 2.25 mg/mL D-glucose and 10 mM DTT. 
An equal mixture of TRITC-labeled and unlabeled bovine brain tubulin (Cytoskeleton 
Inc.) was polymerized as described in Materials and Methods section 2.4.2.2 and 50 mL 
of polymer solution (12.5 mg/mL or 110 nM polymerized dimers in motility buffer+OS) 
was perfused through the chamber and incubated for 2 minutes at room temperature. 
Unbound MTs were removed with 50 mL of motility buffer+OS followed by 100 mL of 
minimal buffer (50 mM Pipes-OH [pH 6.85], 2 mM MgCl2 and 10 mM Taxol) before 
various concentrations of MP (pre-equilibrated in minimal buffer) were perfused 
through the chamber (50 mL) and incubated for 30 seconds at room temperature. 
Perfusion chambers were washed with a further 50 mL of minimal buffer, placed on the 
stage of a Nikon Eclipse E800 microscope and fluorescent microtubules on the upper 
surface of the chamber were visualized using a G-2A (Nikon) filter set. To initiate 
kinesin motor activity, 100 mL of motility buffer+OS (without KCl) was perfused 
through the chamber and images of microtubules were recorded every 1.25 seconds 
using an ORCA-100 progressive scan interline charge-coupled-device (CCD) camera 
(Hamamatsu Photonics, Japan) and Openlab 3.1 software (Improvision, England). For 
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each experimental condition, the mean velocity of at least 30 MTs were manually 
calculated by comparing the relative position of each respective MT end at known time 
intervals for 2-3 minutes. The statistical difference between mean microtubule 
velocities  following the various treatments were determined using a two-tailed 
unpaired t-test, and the percentage of MTs undergoing any discernible translocation 
was also calculated for each respective MP concentration. 
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3 Results 
3.1 Purification of MP from E.coli 
The MP gene was PCR amplified from a plasmid vector harbouring a cDNA of the 
TMV genome and was subcloned into E.coli expression vector pQE60. Upon 
expression in E.coli, the resulting movement proteins contained a C-terminal -GS(H)6 
affinity tag and was purified by isolation of MP-containing inclusion bodies and Ni2+-
NTA Immobilized Metal Affinity Chromatography (IMAC). Following IMAC, 
aliquots of the Flow-through, Wash and Elution fractions were analyzed by SDS-
PAGE and CCB-staining (Fig. 1). As apparent from the Flow-through fraction, MP 
isolated from inclusion bodies was only partially purified (< 80 % by visual estimation) 
and contained a significant amount of protein that did not interact with the column 
matrix (Fig. 1, lane 1). Notably however, not all of the 30 kDa MP was able to bind the 
matrix, indicating that either the affinity tag was absent from these particular moieties, 
or that the binding capacity of the Ni2+-NTA resin had been exceeded. Wash fraction I 
(Fig. 1, lane 2) contained a relatively low amount of MP (taking a 2 X dilution factor 
into account) and also detectable levels of contaminating protein. The contaminating 
material appeared to diminish in Wash fractions II-IV (Fig. 1, lanes 3-5), although low 
amounts of apparently non-specifically bound MP continued to be present. Initially it 
was presumed that effective MP elution could be achieved by using a step-wise 
Imidazole concentration gradient. This however, proved to be incorrect when a four-
step elution (100–500 mM Imidazole) was performed, since the concentration range 
within which residual contaminants were removed broadly overlapped with the elution 
profile of MP (not shown). The result was unacceptable losses of MP in early 
contaminated eluents and was concomitant with a high dilution (< 0.1 mg/mL) of 
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apparently pure MP in subsequent elution fractions. Further compounding this fact, a 
range of methods intended to concentrate MP (including; Centriconä protein 
concentration [Millipore], microspin-gel filtration [Amersham Biosciences] and 
hypertonic-dialysis), proved largely ineffective. A number of washing regimes were 
performed in an attempt to overcome this problem, and a compromise was reached 
using a single, high concentration of Imidazole (500 mM) and collecting lower fraction 
volumes (Materials and Methods section 2.1.5). High amounts of MP (~ 1 mg/mL) 
were indeed observable in the most immediate Elution fractions (EI-IV; Fig. 1, lanes 6-
9), but also contained contaminating proteins. However, in Elution fractions V-VIII 
(Fig. 1, lanes 10-13), highly purified MP could be obtained in quantities still sufficient 
for the intended downstream applications. It was speculated that as the Imidazole 
concentration initially increased within the matrix, proteins making nominal binding 
contacts with Ni2+ were preferentially eluted early (i.e. E.coli proteins with accessible 
histidines or MP interacting via < 6 histidines), whereas MP interacting by virtue of the 
entire His-tag eluted when the Imidazole concentration reached the necessary 
threshold. 
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Figure 1 Purification of MP from E.coli by Ni2+-NTA affinity chromatography. 
MP was expressed in E.coli and inclusion body proteins were solubilized with 
solubilization buffer containing 5 mM Imidazole (SB5). Following IMAC (Materials 
and Methods section 2.1.5) 10 mL aliquots of each resulting fraction were analyzed by 
SDS-PAGE and CCB-staining. Both contaminating E.coli proteins and MP can be seen 
in the Flow-through fraction (lane 1) and after further washing with SB5 (lanes 2 and 3) 
and SB20 (lanes 4 and 5), only non-specifically bound MP is detectable. Elution with 
SB500 led to fractions containing both MP and E.coli proteins (lanes 6-9), however, 
purified MP began to elute in subsequent fractions (lanes 10-13). MP (30 kDa) is 
indicated by the star (*). 
 
 
* 
1       2      3      4       5       6       7       8      9     10    11     12      13 
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3.1.1 Determination of MP purity 
Following renaturation (Materials and Methods section 2.1.6), 10 mg of MP was 
analyzed by SDS-PAGE and CCB-staining. As was typical for most preparations, the 
purity of 30 kDa MP was estimated to be above 95 % (Fig. 2b). Western blots probed 
with a polyclonal antibody reactive against the C-terminus of MP confirmed that the 30 
kDa protein was indeed MP (not shown). According to the SwissProt protein database, 
the E.coli. genome encodes nearly 200 proteins with molecular weights ranging 
between 29 and 31 kDa. To determine whether any contaminating proteins within this 
range were being masked by the presence of 30 kDa MP on SDS-PAGE gels, the 
protein content of this band was analyzed by in-gel Lys-C digestion and LC-MSMS 
(Materials and Methods section 2.1.7.). Using this highly sensitive method (fmol 
detection) it was possible to assign 19 different peptides to MP, confirming 78.7% of 
the total amino acid sequence (Fig. 2a and c). Oxidized and acetylated amino acids 
within the peptides were taken into account and although the entire sequence of MP 
was not covered, the number, and relative abundance of non-assignable peptides was 
sufficiently low that the 30 kDa band could be considered pure MP. 
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Fig 2 Determination of MP purity. (a) Base peak LCMS chromatogram of Lys-C 
digested MP (10 mg). The peaks represent the most intense ionized peptides eluting 
from the HPLC matrix prior to MSMS sequence determination. Oxidized or acetylated 
amino acids are indicated as Knox and KnAc, respectively. (b) CCB-stained SDS-PAGE 
gel containing 10 mg of MP following renaturation. The box indicates the area of gel 
excised for Lys-C in-gel digestion. (c) Peptide sequences attributable to MP, as 
determined by LC-MSMS analysis.  
(c) Peptide Sequence  
 
K1  ALVVK 
K1Ac  AcALVVK 
K3  VNINEFIDLTK 
K5ox  ILPSMOxFTPVK   
K5  ILPSMFTPVK 
K6+7Ac  SVMCSKAcVDK 
K8  IMVHENESLSEVNLLK 
K10  LIDSGYVCLAGLVVTGEWNLPDNCRGGVSVCLVDK 
K11  RMERADEATLGSYYTAAAK 
K14Ox  VVPNYAITTQDAMOxK 
K14  VVPNYAITTQDAMK 
K15  NVWQVLVNIRNVK 
K14 +15Ac VVPNYAITTQDAMKAcNVWQVLVNIRNVK 
K16   MSAGFCPLSLEFVSVCIVYRNNIK 
K18 (3x) Ox  ITNVRDGGPMOxELTEEVVDEFMOxEDVPMOxSIRLAK 
K18  ITNVRDGGPMELTEEVVDEFMEDVPMSIRLAK 
K23  NSSNDRSVPNK 
K25  DFGGMSFK 
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3.2 In vitro RNA binding by MP 
Although it is has been documented that tobamovirus MPs bind RNA sequence non-
specifically in vitro (Citovsky et al., 1990), it was imperative that we determined 
whether our renatured MP had retained such an activity. One of our principle aims was 
to investigate the potential influence that RNA may exert on interactions between MP 
and MTs in vitro, and furthermore, by comparing the RNA binding activities of MP 
mutants in vitro to the infection phenotypes of corresponding mutant viruses, 
inferences might be made as to the mechanism of TMV dysfunction in planta (Boyko 
et al., 2002). 
3.2.1 RNA binding behaviour of MP in vitro 
As demonstrated by the standard RNA band-shift assay (Fig. 3a), MP purified from 
E.coli still had the capacity to interact with RNA in vitro. At stoichiometries between 
1-2 MP per RNA, MP formed a migratory complex with RNA, which remained 
apparent until high concentrations of MP were applied (> 5 MP per RNA). Above this 
protein:RNA ratio, there appeared to be a transition from the migratory complex to a 
non-migratory form which was retained in the well. Although inconclusive, it is 
unlikely that this retarded complex was solely the result of buffer-induced MP 
aggregation, since MP treated under almost identical conditions (minus RNA) and 
subjected to ultracentrifugation at 100,000 x g, remained soluble in the supernatant (not 
shown). As shown in Fig, 3b, reaction conditions were modified to accommodate TMV 
genomic RNA and the band-shift assay was repeated. Even at apparently high 
MP:RNA stoichiometries (# 50 MP per RNA), no discernible shift in RNA migration 
was observed, however, when a greater amount of MP was used, a total retention of 
RNA in the well again became apparent. Interestingly, when the stoichiometries were 
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expressed in terms of MP per nucleotide (nt), it was found that this retardation had 
occurred at between 1 MP per 68–136 nt which was comparable with the stoichiometry 
sufficient to cause a migratory band-shift using the smaller probe (1 MP per 75-150 
nucleotides). The fact that the genomic RNA was retained in the well may simply 
reflect the sheer theoretical size of the protein-RNA complex (> 5 MDa). It remains 
unclear whether the MP-RNA complexes formed by each respective method are 
equivalent, although to a certain extent, these results support the commonly held notion 
that MP binds RNA in a cooperative manner (Citovsky et al., 1992; Boyko et al., 
2002).
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Figure 3 RNA binding activity of MP in vitro 
Increasing amounts of purified MP were incubated with 10 nM of a short (123 nt) 32P-
labeled RNA (a) or a 6.7 kb TMV-derived RNA (b) and resulting complexes were 
separated by non-denaturing agarose gel electrophoresis and visualized as described in 
Materials and Methods section 2.2. At a ratio of between 1-2 MP per RNA 
(corresponding to 1 MP per 75-150 nt), a clear migratory shift of the short RNA is 
observed (a). This migratory complex increases in intensity at higher MP 
concentrations, concomitant with the appearance of more extensively retarded RNA-
protein complexes. Similarly, the TMV-derived RNA (b) was shifted at a molar ratio 
of between 50-100 MP per RNA (1 MP per 68-136 nt), although the resulting 
complexes were of all of a non-migratory nature. In control reactions, TMV-derived 
RNA was not shifted by BSA at a protein:RNA ratio of 400:1. 
Well 
Shift 
Probe 
[MP] / [RNA] 
Well 
Probe 
[MP] / [RNA] 
0      0.03     0.2      0.3     0.8      1.7      2.5      6.7       10 
0               50               100            200            400  
(b) 
(a) 
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3.3 Infection of Nicotiana benthamiana and BY-2 protoplasts 
with TMV encoding MP fused to –(H)6 affinity tags 
In order to investigate whether TMV harbouring an MP-(H)6 fusion protein remained 
infectious or indeed, whether the presence of polyhistidine per se interfered with the 
known subcellular localization of MP:GFP, we transfected BY-2 protoplasts with 
TMV-derived RNA encoding MP:GFP, MP:(H)6:GFP or MP:GFP:(H)6. Although the 
correct localization of MP in BY-2 protoplasts is indicative of MP-mediated cell-to-cell 
movement function in planta (Heinlein et al., 1998), this activity was directly 
determined by inoculating intact leaves of N. benthamiana plants with the above RNA 
transcripts and visualizing infection sites by fluorescence microscopy. 
3.3.1 Infection of BY-2 protoplasts 
At 18 hours post transfection (hpt), TMV-MP:GFP had clearly replicated and GFP 
fluorescence could be localized to MTs (Fig. 4a-c), an observation consistent with the 
cell-to-cell movement function of MP in planta. Similarly, both TMV-MP:(H)6:GFP 
and TMV-MP:GFP:(H)6 were able to produce an infection phenotype comparable to 
TMV-MP:GFP at 18 hpt and localization of –(H)6 tagged MP:GFP with microtubules 
could be observed in both cases (Fig. 4f and i). Although not directly demonstrative of 
MP cell-to-cell movement function, these data do illustrate that six consecutive 
histidine residues do not interfere with MP localization. Expression of free GFP from a 
MP and CP attenuated TMV construct results in the diffuse, cytoplasmic localization of 
GFP fluorescence (Heinlein et al., 1995). For reasons not fully understood, the degree 
of MP:GFP fluorescence found in association with MTs appeared to vary, with some 
MTs apparently more heavily decorated with MP:GFP than others. Although the 
relative amount of MP:GFP in association with MTs was comparable for the viruses 
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tested (not shown), on microtubules displaying heavy MP:GFP association, there was a 
corresponding weak immunohistochemical labeling of tubulin. Although inconclusive, 
this observation indicated that along stretches of MTs where tubulin was poorly 
labeled, MP was in the proximity of the MT surface in large amounts, or that at least 
some of the MP was occupying the antigenic site via a direct interaction, resulting in 
steric hindrance of the antibody-tubulin interaction.  
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Figure 4 Infection of BY-2 protoplasts with TMV-derivatives encoding –(H)6 
affinity tags. Tobacco BY-2 protoplasts were transfected with RNA derived from 
TMV-MP:GFP (a, b and c), TMV-MP:(H)6:GFP (d, e and f) and TMV-MP:GFP:(H)6 
(g, h and i), respectively. At 18 hpt, cells were chemically fixed and immuno-labeled 
with anti-a-tubulin antibody. As determined by the onset of GFP fluorescence, all three 
viruses were considered infectious in protoplasts, and the respective MP:GFP 
chimaeras could be clearly associated with filamentous structures (a, d and g). 
Antibody labelling of a-tubulin (b, e and h) and analysis of the merged composite 
images (c, f and i) confirmed that MP:GFP was localized to microtubules in all three 
cases, an observation consistent with the cell-to-cell movement function of MP.  
(a) (b) (c) 
(d) (e) (f) 
(g) (h) (i) 
10 mm 3 mm 
GFP a-tubulin merge 
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3.3.2 Infection of N. benthamiana 
As a test for viral infectivity and MP-mediated intercellular trafficking of vRNA, 
infectious RNA in vitro transcribed from pTf5-MP:GFP (NSPAX), pTf5-MP:(H)6:GFP 
and pTf5-MP:GFP:(H)6 (Materials and Methods section 2.3.1) were used to inoculate 
leaves of N.benthamiana plants. At 3 days post inoculation (dpi), infected leaves were 
detached, illuminated with UV light and photographed using a digital camera (Fig. 5a, 
c and e). In all three cases, fluorescent infection sites were clearly visible, indicating 
that each respective TMV-derived virus retained both the capacity to replicate, and also 
to move cell-to-cell. In the case of TMV-MP:(H)6:GFP, the resulting infection sites 
were brighter than those caused by either TMV-MP:GFP or TMV-MP:GFP:(H)6 (Fig. 
5b), however, this increase in fluorescence did not correlate with an increase in the 
average infection site area (Fig. 5a) In contrast, both the average size and relative 
brightness of infection sites caused by TMV-MP:GFP:(H)6 were lower than those of 
TMV-MP:GFP or TMV-MP:(H)6:GFP (Fig. 5a and b). In order to determine whether –
(H)6 interferes with the known subcellular localization of MP:GFP in planta, infection 
sites produced by each respective TMV-derivative were compared by fluorescence 
microscopy (Fig. 6b, d and f). The subcellular distribution of TMV-MP:GFP in cells 
throughout the infection site were found to be consistent with previous reports of a coat 
protein attenuated TMV-derivative virus expressing an MP:GFP fusion protein 
(Heinlein et al., 1998). Briefly, in cells adjacent to the leading (outer) edge of infection, 
MP:GFP was localized to cell wall sites. As one observed cells progressively closer to 
the centre of infection, MP:GFP could be first seen to associate with cytoplasmic 
inclusion bodies, then both smaller inclusion bodies and filamentous structures, 
filamentous structures only, and in cells closest to the centre, again cell wall proximal 
sites. This characteristic range of MP:GFP subcellular distributions throughout the 
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infection site was also observed for MP:GFP expressed from TMV-MP:(H)6:GFP and 
TMV-MP:GFP:(H)6, respectively. It should be noted that in almost all cells infected 
with TMV-MP:(H)6:GFP, significantly higher amounts of MP:GFP could be detected 
in sites adjacent to the cell wall. Although this may account for the overall brightness 
of the resulting infection sites, the presence of –(H)6 appeared to have little apparent 
effect on the ability of MP:(H)6:GFP or MP:GFP:(H)6 to associate with MTs (Fig. 6b, d 
and f). This result also highlights that the reduced rate of TMV-MP:GFP:(H)6 spread 
was probably not due to aberrant localization of MP:GFP:(H)6. Although it is apparent 
that MP:GFP:(H)6 accumulated to lower levels than the other MP:GFP fusion proteins, 
the precise mechanisms governing the level of MP and rate of vRNA movement 
remain unclear.  
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Figure 5 Analysis of infection sites on Nicotiana benthamiana leaves caused by 
TMV-derivatives encoding –(H)6 affinity tags. Leaves infected with TMV-MP:GFP, 
TMV-MP:(H)6:GFP or TMV-MP:GFP:(H)6 were detached 3 days post infection and 
recorded under UV illumination by digital photography. The area and average pixel 
intensity within resulting infection sites were determined densitometrically, and as 
shown in (a), infection sites caused by both TMV-MP:GFP and TMV-MP:(H)6:GFP 
were comparable in size (2.48 ± 0.13 and 2.49 ± 0.15 mm2, respectively). In contrast, 
infection with TMV-MP:GFP:(H)6 led to an average infection site area of 1.76 ± 0.13 
mm2, indicating a reduced rate of vRNA cell-to-cell movement. Relative to MP:GFP 
fluorescence (18.1 ± 1.0 arbitrary units), MP:(H)6:GFP appeared to overaccumulate 
(35.4 ± 2.1 arb. units), although a corresponding increase in infection site area was not 
apparent (b). The depreciated level of MP:GFP:(H)6 fluorescence (9.6 ± 0.6 arb. units) 
did correlate with a reduced infection site area, however, the possibility that –(H)6 
caused MP to mislocalize could not be discounted without further microscopic 
analyses. Error bars represent the standard error of the mean. 
(a) 
(b) 
MP:GFP     MP:(H)6:GFP    MP:GFP:(H)6 
  
66
 
 
Figure 6 Infection of Nicotiana benthamiana leaf epidermal cells with TMV- 
derivatives encoding –(H)6 affinity tags. Expanded leaves of N. benthamiana plants 
were mechanically inoculated with RNA derived from TMV-MP:GFP (a and b), TMV-
MP:(H)6:GFP (c and d) and TMV-MP:GFP:(H)6 (e and f), respectively. At 3 days post 
infection, detached leaves were visualized by UV-digital photography (a, c and e) and 
fluorescence microscopy (b, d and f). As determined by the appearance of expanding 
(e) 
(d) (c) 
(f) 
30 mm  1 mm 
(a) (b) 
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fluorescent infection sites, all three viruses were considered infectious with regard to 
viral replication and intercellular trafficking of vRNA. Although of a similar size, 
infection sites caused by TMV-MP:(H)6:GFP (c) appeared to be brighter than those due 
to TMV-MP:GFP (a), possibly reflecting enhanced MP:(H)6:GFP expression. In 
contrast, the infection sites caused by TMV-MP:GFP:(H)6 (e) appeared to be both 
smaller, and less fluorescent than TMV-MP:GFP induced sites, however, microscopic 
analysis revealed that for each respective virus, the subcellular distribution of MP:GFP 
fluorescence was largely consistent with previous reports (Heinlein et al., 1998). 
Although inconclusive, MP:(H)6:GFP accumulation in cell wall proximal sites (d) 
appeared to account for the relatively high fluorescence of infection sites caused by 
TMV-MP:(H)6:GFP. Nevertheless, in cells behind the leading edge (LE) of infection 
(arrow), MP:GFP, MP:(H)6:GFP and MP:GFP:(H)6 could be localized to filamentous 
structures characteristic of microtubules (b, d and f; Boyko et al., 2000a), thereby 
indicating that all three fusion proteins were indistinguishable with regard to MT 
association. Although the presence of –(H)6 had subtle effects on the level of MP 
accumulation and rate of vRNA trafficking, these data do collectively demonstrate that 
viral replication, cell-to-cell trafficking and MP:MT association are not inhibited by –
(H)6 to the point of rendering the TMV-derivative viruses non-viable.  
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3.4 Biochemical analysis of MP:MT binding in vitro 
3.4.1 Optimization of reaction conditions 
The reaction buffer BRB80 (80 mM Pipes-OH [pH 6.8], 1 mM MgCl2, 1 mM EGTA) 
containing GTP is commonly used for MT-based biochemical assays (Ackmann et al., 
2000). Attempts to directly perform the MAP assay (Materials and Methods section 
2.4.3) with MP using this buffer system resulted in an apparent non-saturable and 
linear binding relationship (not shown). Direct visualization of these ‘complexes’ by 
immunohistochemical labeling of a-tubulin and MP followed by fluorescence 
microscopy demonstrated that MP had formed large, irregular-shaped aggregates on 
and around extensively bundled MTs (not shown). Regardless of the evident MP-MT 
interaction, non-specific aggregation could not discounted as the sole determining 
factor. Due to this experimental constraint, interpretations of the binding reaction 
remained unreliable. To improve the stability of MP, a systematic approach was 
established whereby MP solubility was tested in a range of buffers empirically known 
to support MT polymerization (Lee and Timasheff, 1977; Waxman et al., 1981; 
Pedrotti et al., 1993). Briefly, MP was incubated in premixed buffer, centrifuged and 
the pellet and supernatant fractions were analyzed by SDS-PAGE and CCB staining. 
Table 2 summarizes a number of MT-compatible conditions within which MP 
solubility was tested. As mentioned, buffer BRB80 (+ GTP) induced the otherwise 
soluble MP to aggregate. Solubility in this buffer could not be improved by the 
presence of 10 % (v/v) glycerol or by non-ionic detergents in micelle concentrations 
(Table 2, 2-8). Testing the BRB80 components individually showed that GTP was the 
causal agent of MP insolubility when present at 1 mM (Table 2), a concentration 
typically used to facilitate net MT stability in vitro. As a possible substitute for GTP, 
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the non-hydrolyzable analogue, Guanosine 5’-[g-thio]-triphosphate (GTP-g-S) was also 
tested and found to produce a similar level of MP aggregation. Although not shown, it 
was also found that a number of salts (e.g. H2PO4-, Na+ and K+) at concentrations 
below 50 mM effectively “salted-out” MP from solution. This observation was not 
entirely unsurprising given that MP has been shown by subcellular fractionation 
experiments to behave as an integral-membrane protein (Reichel et al., 1999), and that 
many such proteins have a general propensity to aggregate in low concentrations of salt 
(Prof. M. Spiess, personal communication). Additionally, it was found that buffers 
containing 80 mM Pipes-OH (pH 6.8) induced a less pronounced, yet detectable 
decrease in MP solubility (Table 2, 4-5). Although considered to be minor (< 5 % loss 
of MP in pellets), it was speculated that the effects of ~ 150 mM ionic strength (Seitz et 
al., 2002), may still lead to extraneous non-specific binding and thus, overestimation of 
the MP:MT binding stoichiometry (Timasheff, 2002). MP was therefore tested in more 
dilute buffer (12 mM Pipes-OH [pH 6.8]) and was indeed found to remain soluble even 
when stored for a period of days at 4 oC. It should be noted that a hydrophobic 
component to the MP-MT interaction during infection cannot be ruled out, however, it 
was hoped that by reducing the ionic strength of the buffer to a minimum, the 
biochemical analysis in vitro could be somewhat simplified. Since GTP was now 
known to induce MP aggregation, both GTP and unpolymerized tubulin dimers were 
removed from the MT polymer fraction by repeatedly pelleting and resuspending MTs 
into GTP-free buffer. In vitro, MTs spontaneously convert between phases of 
elongation and shortening, and since MTs require GTP for the elongation phase of their 
dynamics, the absence of exogenous GTP results in a net breakdown of MTs over time 
(Caplow and Fee, 2003). To counteract this fact, pelleted MTs were resuspended in 
GTP-free buffer containing the drug taxol, a strong suppressant of MT dynamics 
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(Wilson et al., 1985; Derry et al., 1995). Glycerol was also included in the MAP 
binding buffer to additionally enhance MT stability (Prof. A. Hoenger, personal 
communication). Providing the polymerized MTs were allowed to equilibrate in the 
presence of taxol and GTP (³ 12 hours) before being resuspended in MAP binding 
buffer (12 mM Pipes-OH [pH 6.85], 0.5 mM MgCl2, 10 % [v/v] Glycerol, 0.01 % [v/v] 
Tween-20 and 10 mM Taxol), MTs remained almost totally stabilized in the absence of 
GTP for at least 30 minutes following buffer exchange (Fig. 7b).  
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Table 2 Solubility of MP in microtubule-compatible buffers. In order to 
determine which component of the reaction buffer BRB80 (80 mM Pipes-OH [pH 6.8], 
1 mM MgCl2, 1 mM EGTA [+ 1mM GTP]) was responsible for MP aggregation, MP 
was incubated in the above buffer compositions, incubated for 1 hour and subjected to 
high-speed centrifugation as described in Materials and Methods section 2.4.2.1. The 
resulting pellet and supernatant fractions were analyzed by SDS-PAGE and CCB 
staining and if 95% or more of MP remained in the supernatant, the protein was 
considered to be soluble in that particular buffer (as indicated). Using this approach it 
was possible to identify GTP as the causal agent of MP aggregation (highlighted in 
red). All other standard components of BRB80 had no significant effect on the 
solubility of MP. As a potential substitute for GTP, the structural analogue GTP-g-S 
was tested and also found to induce comprehensive MP aggregation. Neither micelle 
concentrations of non-ionic detergents nor glycerol appeared to have any positive 
effect on the solubility of MP. 
80 mM Pipes-OH, pH 6.8 
12 mM Pipes-OH, pH 6.8 
1 mM Mg Cl2 
1 mM EGTA 
1 mM GTP 
1 mM GTP-g-S 
25 mM Taxol 
10 % (v/v) Glycerol 
1 % (v/v) Nonidet-P40 
0.1 % (v/v) Nonidet-P40 
1 % (v/v) Triton X-100 
0.1 % (v/v) Triton X-100 
0.01 % (v/v) Tween-20 
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Figure 7 Examples of the microtubule stability assay. MTs were polymerized as 
described in Materials and Methods section 2.4.2.2 and were resuspended in 60 mL of 
either 10 mM Tris-Cl (pH 7.5), 1 mM MgCl2 and 25 mM Taxol (a), or MAP binding 
buffer (12 mM Pipes-OH [pH 6.85], 0.5 mM MgCl2, 10 % [v/v] Glycerol, 0.01 % [v/v] 
Tween-20 and 10 mM Taxol), as shown in panel (b). Samples were incubated for 30 
minutes and polymerized tubulin was sedimented by centrifugation. Pellet (P) and 
supernatant (S) fractions were analyzed on separate SDS-PAGE gels by CCB staining. 
MTs were highly unstable in Tris-based buffers (pH 6.8 or pH 7.5), regardless of the 
presence of Taxol. It was found that even upon dilution, and in the absence of GTP, 
stable MTs could be maintained when Pipes (pH 6.8-7.0) was employed as the 
buffering agent in the presence of Taxol.  
P S P S 
(a) (b) 
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3.4.2 MAP assay 
The microtubule binding activity of MP was tested using the optimized MAP binding 
buffer (Materials and Methods section 2.4.3). In order to fulfill the criteria for 
saturation binding analysis, increasing amounts of MP was titrated over 3 orders of 
magnitude (sub-supramolar) against a fixed concentration (1.1 mM) of polymerized 
tubulin dimers. Following incubation, MTs and associated MP were sedimented and 
both the pellet and supernatant fractions were analyzed by SDS-PAGE and CCB 
staining. As can be seen in Fig. 8, an absence of tubulin in the supernatant fractions 
indicated that the MTs remained dynamically stable throughout the course of the 
reaction. Saturable binding was apparent as determined by the appearance of MP in 
supernatant fractions at a 3:1 molar ratio of MP to tubulin and above. Replicate 
experiments using freshly prepared MTs and MP produced directly comparable results. 
However, due to the detection threshold of CCB, it was speculated that saturation of 
MT binding sites by MP might not be seen at MP concentrations below 3 mM. Reaction 
volumes were therefore increased 3-fold for reactions containing between 0.1 and 3 
mM MP (not shown). Although more MP could be seen in the supernatant fraction in 
this case, the ratio at which MP became visible remained the same at approximately 
3:1. To control for buffer-induced aggregation of MP, reactions were repeated in the 
absence of tubulin. In some cases very low amounts of MP could be detected in the 
pellet fractions and where applicable, these amounts were accounted for when 
calculating the amount of MP per lane.  
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Figure 8 Microtubule binding by MP in vitro. Increasing amounts of MP were 
incubated with 1.1 mM of polymerized tubulin dimers in MAP binding buffer and MTs 
together with associated MP were sedimented by centrifugation. Pellet (top panel) and 
supernatant (bottom panel) fractions were analyzed by SDS-PAGE and CCB staining. 
Detectable levels of tubulin are exclusively found in the pellet fractions, indicating that 
the MTs remained stable under the reaction conditions used. In addition, the presence 
of MP in the pellet fractions demonstrates that MP had the capacity to interact directly 
with pure MTs. This interaction was saturable as determined by the increasing presence 
of MP in the supernatants at an MP:tubulin ratio of 3:1 and above. Although not 
shown, when reaction volumes were increased 3-fold, the ratio at which MP was 
detectable in the supernatant remained about 3:1, suggesting that the detection 
threshold of CCB (~ 50 ng MP) was not a limiting factor. 
Tubulin 
MP 
MP 
0.1    0.25     0.5       1        2         3         4         5        6        7        8        10 [MP], mM 
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3.4.3 Determining the effect of –(H)6 on MT binding 
The association of MAPs with MTs is thought to arise predominantly via ionic 
interactions (Cassimeris and Spittle, 2001). At a pH of 7.0 (reaction pH = 6.8) the 
predicted charge of –(H)6 is + 1.42 (ProtParam, IK@N Bioinformatics), therefore, 
using a similar approach to the MAP assay, we tested whether –(H)6 is sufficient to 
directly mediate MT binding contacts. Test proteins GST-(H)6, (H)6-Tau 441 or MP-
(H)6 (all at 1.5 mM) were incubated with (+) or without (-) a molar excess of 
polymerized tubulin (6 mM) and pelleted material was analyzed by SDS-PAGE and 
CCB staining. As expected, approximately all of the MP cosedimented with MTs (Fig. 
9, lane 11), as compared to the starting amount of material (Fig. 9, lane 10). In the 
absence of tubulin, soluble MP remained exclusively in the supernatant (Fig. 9, lane 
12). A similar result was obtained using recombinant (H)6-Tau, a well characterized 
neuronal MAP (Fig. 9 lanes, 4-6). In contrast, neither soluble GST-(H)6 (Fig. 9, lanes 
1-3) or BSA (Fig. 9, lanes 7-9) appeared to cosediment with tubulin to any significant 
degree, taking into account the molar excess of MTs. Although these results 
demonstrate that a -(H)6 affinity tag is insufficient to produce stoichiometric MT 
binding in vitro, low amounts of GST-(H)6 and BSA did cosediment with tubulin. The 
amount of non-specific binding was comparable in both cases, however, the degree to 
which –(H)6 contributed to this interaction, and whether a similar non-specific 
component is involved in the MP-MT interaction remains unclear. 
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Figure 9 MAP assay control reactions to determine the effect of –(H)6 on 
microtubule binding in vitro. Test proteins (1.5 mM) were incubated either with (+) or 
without (-) 6 mM polymerized tubulin in MAP binding buffer and subjected to 
centrifugation. Pellet fractions were analyzed by SDS-PAGE and CCB staining. The 
position of tubulin is denoted by (*) and for visual comparison, 1.5 mM of each test 
protein was directly loaded on the gel without prior centrifugation (input). In the 
absence of tubulin (lanes 3,6,9 and 12), the apparent lack of protein in the pellets 
indicated that all four test proteins remained soluble under the conditions used. A small 
amount of GST-(H)6 was observed to cosediment with MTs (lane 2), however, 
compared to the starting amount of material (lane 1) this degree of binding appeared to 
be neglible, possibly reflecting a weak non-specific interaction. Similarly, BSA also 
did not bind MTs to any significant amount (lane 8), as compared to the starting 
amount of protein (lane 7). Conversely, with a molar excess of tubulin, almost 
complete binding of (H)6-Tau (lane 5) and MP (lane 11) could be observed. Although a 
non-specific component to this binding could not be ruled out, the collective data 
suggested that a –(H)6 moiety alone was insufficient to mediate strong interactions with 
MTs in vitro. 
 Input    (+)      (-)    Input    (+)     (-)     Input    (+)     (-)    Input     (+)     (-) 
GST-(H)6 (H)6-Tau BSA MP-(H)6 
* 
1         2        3        4        5        6        7        8        9        10      11      12 
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3.4.4 Analysis of the MT binding properties of MP in vitro 
Following the MAP assay, the amount of MP in the pellet ([MP]bound) and supernatant 
([MP]free) fractions was quantified by densitometry of the digitized gels. The amount of 
MP in each respective fraction was corrected for non-specifically pelleted MP and, 
subsequently, values for [MP]bound were plotted versus [MP]free, yielding a saturation 
hyperbole. In an attempt to characterize the equilibrium binding reaction, a curve was 
fit to these data according to a simple model describing a receptor:ligand binding 
reaction where only one type of ligand binding site exists, and all binding sites of this 
type are independent and do not display an allosteric influence on subsequent ligand 
binding (Appendix III eq. 11). It must also be assumed when using this model that 
there is a single type of monovalent ligand, when values for the binding stoichiometry 
and Kd are required. As can be seen in Fig. 10, a curve fit using the one-site model did 
not pass smoothly through all data points, a fact reflected in the relatively low value of 
r2 = 0.967 (an indicator that actual data deviate from the model-dependent predicted 
curve). Nonetheless, non-linear regression analysis of this curve yielded apparent 
values of Kd = 71.6 ± 14.5 nM with a stoichiometry of 2.8 ± 0.12 MP/tubulinmonomer. 
The Kd value determined by this method was within the range commonly found for 
other MAPs (Ackmann et al., 2000), although it should be noted that since a low ionic 
strength buffer was employed, and MAP binding is thought to result largely via ionic 
interactions, the apparent affinity of MP for MTs may be slightly enhanced. The value 
for stoichiometry was considered to be high, therefore, in order to determine whether 
the one-site model was indeed appropriate, Scatchard-Rosenthal plots were produced 
by plotting [MP]bound/[MP]free versus [MP]bound according to the Scatchard equation 
(Appendix III eq. 13; Fig. 11, inset). In theory, adherence to the above criteria would 
result in a straight line with a slope of –1/Kd and stoichiometry found at the x-intercept. 
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Manually fitting a curve to these data illustrated a clear deviation from the predicted 
straight line relationship (Fig. 11) and in fact resulted in a line of upward curvature. 
Scatchard curves of this type can be interpreted in a number of ways (Norby et al., 
1980; Zierler, 1989). For instance, the existence of more than one type of ligand 
binding site on a receptor can account for apparently biphasic curves, and are usually 
attributable to sites with differing affinities for the same ligand. In this case, 
independence is assumed both within and between types of binding site. Alternatively, 
one may infer that ligand binding undergoes homotropic allosterism, that is, initial 
binding of ligand to a single type of binding site has a negative influence on subsequent 
ligand binding to the same type of site. In an attempt to differentiate between the 
underlying binding mechanisms, a curve was fit to plots of [MP]bound versus [MP]free 
according to a two-site model (Appendix III eq. 12), where binding site independence 
was again assumed. In this case, non-linear regression yielded two values for Kd and 
stoichiometry (Kd1 = 31.3 ± 16.6 nM; n1 = 1.81 ± 0.55; Kd2 = 1.56 ± 1.34 mM; n2 = 1.56 
± 0.436), indicating both a high and low affinity MP-binding site on tubulin. The 
overall fit of the line was improved (Fig. 12; r2 = 0.986) as compared to the one-site 
model, and comparison of the two curves by one-way analysis of variance (Fig. 13; F = 
4.72, P = 0.026) indicated that statistically, a two-site model was indeed the more 
appropriate. It should be noted that absolute values obtained from Scatchard plots are 
rendered unreliable due a deviation from the Gaussian distribution during data 
transformation. Taken together with the statistically strong fit of a two-site model, it is 
tempting to conclude that MP binds alternative sites on tubulin, however, whether the 
second site actually resides on the surface of tubulin, or occurs via a tubulin:MP:MP 
ternary complex remains a matter of conjecture. Additional complexities arise due to 
insufficient knowledge regarding the homogeneity of MP. Since it is possible that 
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multivalent or alternative folded states of renatured MP exist, and indeed, the low 
affinity site may represent a non-specific binding site, further experimentation is 
clearly required in order to make a categorical conclusion about the mechanistic nature 
of the MP:MT interaction in vitro.  
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Figure 10 Equilibrium binding of MP to MTs in vitro: one-site model. Equilibrium 
binding experiments were performed by incubating purified MP (0.1-10 mM) with in 
vitro polymerized tubulin (2.2 mM monomer) before bound and unbound MP was 
separated by centrifugation and analyzed by SDS-PAGE and CCB staining. Values for 
[MP]bound and [MP]free were determined by densitometry as described in Materials and 
Methods section 2.4.5. Plotting [MP]bound versus [MP]free gave a saturation hyperbole 
and a curve was fit to these data according to the binding model describing a single 
type of non-interacting binding site on tubulin (Materials and Methods section 2.4.5). 
The fit curve was analyzed by non-linear regression and yielded an apparent Kd of 71.6 
± 14.5 nM, a value comparable to other characterized MAPs. The curve saturated at an 
apparent stoichiometry of 2.8 ± 0.12 equivalent binding sites per tubulin monomer. 
Because the curve did not pass smoothly through all of the data points (r2 = 0.967; 
where 1 indicates a perfect fit), it remains feasible that a one-site model does not 
adequately describe these data. 
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Figure 11 “Linearization” of equilibrium binding data: Scatchard-Rosenthal plot. 
Equilibrium binding experiments were performed as described in Materials and 
Methods section 2.4.3 and values of [MP]bound/[MP]free were plotted versus [MP]bound. 
According to the Scatchard equation (inset), equilibrium binding data plotted in this 
manner should result in a straight line when the criteria for a single type of 
independent, non-interacting ligand binding site are met. These data clearly deviate 
from the predicted straight line, and therefore, a curve was fit (y = a+b/1+cx) using a 
best-fit trial and error approach (r2 = 0.98). The upwards curvature and apparent 
biphasic nature of this line can indicate the following; negative cooperativity 
(homotropic steric hindrance) in a one-binding site system, the existence of two or 
more independent MP-binding sites per tubulin or a non-specific binding component to 
the reaction (Norby et al., 1980). Care should be taken when interpreting Scatchard 
plots, since following transformation, data no longer adhere to the assumed Gaussian 
distribution. 
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Figure 12 Equilibrium binding of MP to MTs in vitro: two-site model. Equilibrium 
binding experiments were performed as described in Materials and Methods section 
2.4.3 and in this case, a curve was fit to the plot of [MP]bound versus [MP]free according 
to a model describing two types of independent, non-interacting binding sites on 
tubulin (Materials and Methods section 2.4.5). Non-linear regression analysis indicated 
the existence of a high affinity (Kd1 = 31.3 ± 16.6 nM; n1 = 1.81 ± 0.55) and a low 
affinity (Kd2 = 1.56 ± 1.34 mM; n2 = 1.56 ± 0.436, respectively) MP-binding site on 
tubulin. The curve appeared to fit the data relatively well (r2 = 0.986), as compared to 
using a one-site model (Fig. 10). The possibility that the improved fit resulted from an 
increased number of parameters, and therefore inflexion points, could not be 
discounted using this analysis alone. 
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Figure 13 Analysis of MP equilibrium binding to MTs in vitro: comparison of 
binding data fit to a one-site or two-site model. Equilibrium binding experiments 
were performed as described in Materials and Methods section 2.4.3 and curves were 
fit to a plot of [MP]bound versus [MP]free according to models describing a single type of 
independent binding site (a1) or two different independent binding sites (a2). The fit of 
these curves were compared by one-way ANOVA of the non-linear regression data 
obtained for each respective curve fit. The F ratio was calculated (b) assuming a null 
hypothesis (null) that the one-site model fits the data better, and an alternative 
hypothesis (alt) that the two-site model is more appropriate. SS is the sum of the 
squares and df is degrees of freedom. Since the F ratio was found to be greater than 
one, the null hypothesis could be rejected, which was confirmed by the calculated P-
value of 0.026. It could therefore be statistically inferred that in vitro, MP binding to 
MTs is a biphasic reaction involving more than one MP-binding site on tubulin or 
possibly resulting due to multivalent/isotypic forms of MP. 
(a) (b) 
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3.5 Visualization of MP:MT complexes formed in vitro by 
fluorescence microscopy 
3.5.1 Establishment of the perfusion chamber system  
MTs are highly sensitive to their immediate buffer environment, making the direct 
immunolabeling of MAP:MT complexes technically unfeasible without prior fixation. 
Initial attempts to fix MP:MT complexes in free solution resulted in extensive and 
irregular bundling of MTs (not shown). Although MP appeared to colocalize with MTs 
in this case, the presence of large MP aggregates suggested that the interaction may 
have occurred largely through non-specific crosslinking, particularly when MP was in 
molar excess. A system was therefore established whereby immobilized MTs could be 
incubated with MP and unbound protein removed before fixation. Briefly, a simple 
perfusion chamber was coated with a mixture of casein and the molecular motor 
kinesin. In vitro polymerized MTs were anchored to the kinesin in the absence of ATP, 
in order to inhibit motor activity before MP was introduced and allowed to bind MTs. 
Unbound protein was washed out and the resulting complexes were rapidly fixed with 
glutaraldehyde before a-tubulin and MP were immunohistochemically labeled. One 
major drawback to using the perfusion chamber method is that one has no accurate 
knowledge of the actual amount of MTs within the chamber, since this is dependent on 
both the concentration of kinesin and tubulin, and also the time that each respective 
component is absorbed to the chamber. Assuming that every MT was immobilized, the 
maximum theoretical tubulin concentration within the chamber would have increased 
to 0.5 mM, due to a concentration of the original 90 nM solution. As determined by 
visual inspection of rhodamine-labeled MTs before and after absorption, the realistic 
concentration was significantly lower than this figure. Therefore, MP was applied at a 
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wide range of concentrations in an attempt to emulate the MP:Tubulin stoichiometries 
used during the MAP assay. To test for crossreactivity leading to false MP signals, a 
variety of anti-tubulin, anti-MP and secondary antibody combinations were used to 
label MTs undecorated with MP. The following combinations were considered 
suitable; anti-a-tubulin YOL1/34 (a-tubulin residues 414-422) in combination with 
anti-MP-N (MP residues 6-22), or anti-a-tubulin DM1A (a-tubulin residues 426-450) 
in combination with anti-MP-C (MP residues 209-222), respectively. Due to poor 
labeling efficiency, anti-b-tubulin antibodies were not used.  
3.5.2 Fluorescence microscopy 
Using either of the above antibody combinations, it was not possible to observe any 
significant MP colocalization with MTs at MP concentrations below 200 nM (not 
shown). Since estimates of the tubulin concentration were wholly unreliable, it could 
only be speculated that the apparent lack of MP co labeling was either due to 
insufficient amounts of MP, and consequently a fluorescence signal below the 
microscope detection limit, or alternatively, a low signal to noise ratio resulting from 
non-specific binding of MP to the chamber surface. In either case, the tubulin staining 
produced a smooth, consistent fluorescence signal along the length of the MTs. In 
contrast to this, incubations with higher concentrations of MP (0.75-2.5 mM) resulted in 
a noticeably punctate tubulin labeling when either YOL1/34 or DM1A anti-tubulin 
antibody was employed alone, and in extreme cases, an almost total absence of tubulin 
labeling (for examples see Fig. 14, row a). This observation suggested that MP may 
have been present at or near the antigenic sites for either antibody (collectively 
mapping to a-tubulin residues 414-450), and indeed, immunolabeling of MP:MT 
complexes (MP > 0.75 mM) with the antibody combinations described above resulted 
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in apparent MP colocalization along the entire length of the MTs. The distribution of 
MP along the MTs was not uniform, however, and along certain stretches of the MTs, 
the MP labeling appeared to be particularly strong (Fig. 14, row b). Although the 
overall tubulin-specific signal was higher than that of MP, these areas where the MP 
signal was stronger clearly correlated with a largely reduced tubulin-specific signal 
(Fig. 14, row c and d). Although inconclusive, this result indicated that at least in part, 
MP had the capacity to obscure the antigenic site recognised by either anti-tubulin 
antibody, and that residues found at either termini of MP were accessible to anti-MP 
antibodies, possibly suggesting that these regions of MP were not directly involved in 
the MP:MT interaction. Further experimentation, such as the use of truncated or 
mutagenized MP would be required in order to test this hypothesis. It should be noted 
that upon TMV infection of BY-2 protoplasts, MTs heavily decorated with MP:GFP 
are also stained poorly by anti-a-tubulin antibody DM1A, although care should be 
taken when drawing conclusions from such dissimilar experimental systems. 
Biochemical analysis of the MP:MT interaction strongly suggests that equilibrium 
binding deviates from a single ligand, single receptor mechanism. In principle, the 
observed non-uniform distribution of MP along MTs in vitro supports this hypothesis, 
although it must be conceded that due to extensive washing, the above conditions do 
not fully reflect equilibrium binding. Nonetheless, MP complexed with MTs is 
recognized by anti-MP antibodies reactive against both N- and C-termini. Considering 
the possible interpretations of a ‘two-site’ binding model (Results section 3.4.4), the 
above observations favour a binding mechanism whereby MP can interact directly with 
tubulin, although, a less ordered binding reaction may occur, possibly resulting in a 
tubulin:MP:MP ternary complex. Due to the similar predicted binding stoichiometries 
for either mechanism (n1 = 1.81 ± 0.55 and n2 = 1.56 ± 0.436 MP:tubulin dimer), it is 
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not possible using this method to make firm conclusions regarding the relative 
abundance of MP on the MT and the corresponding binding mechanism. Similarly, it 
remains unclear whether non-uniform MP distributions reflect structural differences 
within the MT itself, or indeed, whether MP can interact with b-tubulin. 
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Figure 14 Visualization of MP:MT complexes formed in vitro by 
immunohistochemical labeling and fluorescence microscopy. MTs were 
polymerized in vitro (~ 90 nM tubulin) and immobilized in perfusion chambers 
precoated with kinesin. A molar excess of MP was introduced as indicated, incubated 
for 2 minutes at room temperature and unbound MP was removed with 10 volumes of 
(a)        0.75 mM MP 
(d) 
(c) 
(b) 
2.5 mM MP 1.5 mM MP 
5 mM 
1.5 mM 
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MAP binding buffer. Resulting MP:MT complexes were fixed and labeled with 
antibodies specific for a-tubulin (YOL1/34; row a) and MP (anti-N-term; row b), 
respectively. Under the conditions used, MP could be clearly observed to colocalize 
with the MTs at a level above that of background fluorescence (row a and b). Although 
the overall MP-specific fluorescence was less than the corresponding tubulin signal 
(row c and d), the presence of MP could be correlated with a mere punctate labeling of 
tubulin,. in contrast to MTs or stretches of MTs undecorated by MP that showed strong 
and smooth tubulin labeling (not shown). Moreover, in areas where MP fluorescence 
was particularly strong, an almost complete absence of tubulin staining was observed. 
Although these data do not strictly reflect equilibrium binding (due to excessive 
washing), the non-uniformity of the MP:MT colocalization is in support of biochemical 
evidence that suggests in vitro, MP binds MTs via a bi- or possibly multiphasic 
mechanism. The precise manner by which MP impedes the anti-tubulin:antigen 
interaction remains unclear, although in principle, these data are consistent with 
observations of TMV-infected BY-2 protoplasts in which heavy MP:MT colocalization 
corresponds to a diminished tubulin immunolabeling. 
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3.6 Co-precipitation experiments in vitro using immobilized 
MP as an affinity bait 
3.6.1 Co-precipitation of MTs and tubulin heterodimers in vitro 
It has been described in the literature that certain ‘tubulin’ binding proteins 
preferentially interact with specific structural forms of tubulin such as tubulin dimers 
(Spittle and Cassimeris, 1996; Fukata et al., 2002) or microtubules ends (Carvalho et 
al., 2003; Howard and Hyman, 2003). Therefore, in order to determine whether MP 
can interact with binding contacts found on tubulin dimers or specifically interacts only 
with polymerized tubulin, purified MP was immobilized on Ni2+-NTA sepharose beads 
and used as an affinity bait for the co-precipitation of either in vitro polymerized MTs 
or tubulin dimers. Pellet and supernatant fractions were separated by centrifugation and 
were analysed by SDS-PAGE and Western blotting, and to control for non-specific 
binding of tubulin to sepharose, the same procedure was followed in the absence of 
MP. Western blots probed with anti-MP-C antibody showed that throughout the course 
of the binding reaction, MP remained coupled to the affinity matrix in amounts that 
were comparable between reactions (Fig. 15a). Probing equivalent Western blots with 
anti-a-tubulin antibody showed that even after extensive washing, detectable levels of 
tubulin could be found in pellet fractions containing MP (Fig. 15b). In pellet fractions 
without MP, no tubulin was detected, thereby indicating that precipitation of tubulin 
had occurred via an interaction with MP, and not by virtue of non-specific contacts 
with the sepharose beads. Tubulin did not co-precipitate with Ni2+-NTA sepharose 
beads in the absence of BSA (not shown), again suggesting that an MP:tubulin 
complex had formed, as opposed to an MP:BSA:tubulin ternary complex. Repeating 
the experiment confirmed that under the conditions used, MP interacted more 
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favourably with tubulin dimers than MTs, although the reason for this is not fully 
understood. Also, it cannot be ruled out that what appeared to be an MP:MT interaction 
was actually the result of MT depolymerization and the interaction of MP with tubulin 
dimers or short tubulin oligomers. Nevertheless, the fact that soluble tubulin dimers 
were able to bind MP in vitro suggests that polymer-specific structural forms of tubulin 
are not a prerequisite to MP binding. Furthermore, considering that the –(H)6 tag was in 
close proximity to the affinity matrix, it is likely that residues found at the extreme C-
terminus of MP were inaccessible for tubulin binding, suggesting that the MP:tubulin 
interaction was not mediated solely by this region of MP, an observation in agreement 
with previous reports (Boyko et al., 2000a; Boyko et al., 2000c). Repeating the 
experiment confirmed that under the conditions used, MP interacted more favourably 
with tubulin dimers than MTs, although the reason for this is not fully understood. It 
could be envisaged, however, that while the physical distribution of MP on Ni2+-NTA 
beads may have had a nominal effect on the correct orientation and binding of free 
tubulin dimers to MP, a net reduction in the number of available MP binding sites per 
equivalent (polymerized) tubulin dimer may have occurred, thus resulting in weaker 
overall binding. Also, it cannot be ruled out that what appeared to be an MP:MT 
interaction was actually the result of MT depolymerization and the interaction of MP 
with tubulin dimers or short tubulin oligomers. Nevertheless, the fact that soluble 
tubulin dimers were able to bind MP in vitro suggests that polymer-specific structural 
forms of tubulin are not a prerequisite to MP binding, and furthermore, considering that 
the –(H)6 tag was in close proximity to the affinity matrix, it is doubtful that the 
MP:tubulin interaction occurred solely via the extreme C-terminus of MP. 
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Figure 15 Co-precipitation of MTs and tubulin heterodimers in vitro using 
immobilized MP as an affinity bait. Ni2+-NTA beads conjugated to MP (+ MP) or 
without MP (- MP) were incubated with in vitro polymerized MTs (polymer) or 
tubulin a/b dimers (dimers). Pellet (P) and supernatant (S) fractions were separated by 
centrifugation and analysed by SDS-PAGE and Western blotting using antibodies 
specific against MP or a-tubulin, respectively. As shown in (a), MP remained coupled 
to the Ni2+-NTA beads throughout the course of the binding reaction. In pellet fractions 
containing MP, detectable amounts of both tubulin polymer and tubulin dimers were 
observed (b), although under the conditions used (Materials and Methods section 
2.6.1), the MP:dimer interaction appeared to be favoured. In the absence of MP, no 
tubulin was detected in the pellets, indicating that tubulin co-sedimention with Ni2+-
NTA beads occurred due to an interaction with MP. 
P            S               P             S 
polymer dimers 
anti-MP 
(a) 
+ MP           MP        + MP           MP    
polymer dimers 
anti-a-tubulin 
(b) 
(c) 
Pellet 
Supernatant 
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3.6.2 Co-precipitation of RNA and tubulin heterodimers in vitro 
The putative role of RNA in the MP:tubulin interaction in vitro was investigated using 
an approach whereby MP (theoretical max. 3.25 mM) was immobilized on Ni2+-NTA 
beads and used to co-precipitate combinations of tubulin dimers and RNA. Using a 
two-step approach, MP-conjugated beads were first incubated in the presence of 
tubulin heterodimers (1.63 mM) or the 6.7 kb in vitro transcribed TMV genomic RNA 
(50 nM or ~300 mM polymerized nucleotide). Subsequently, tubulin dimers, RNA or 
pulldown buffer were added to the reaction (as summarized in Fig. 16a) and incubated 
once again. To control for non-specific binding, RNA or tubulin were incubated with 
beads in the absence of MP. Pellet and supernatant fractions were separated by 
centrifugation before RNA was analyzed by non-denaturing agarose gel electrophoresis 
(Fig. 16c) and proteins were analyzed by SDS-PAGE and Western blotting (Fig. 16b). 
When incubated alone with MP-conjugated beads, both tubulin dimers (Fig. 16b1) and 
RNA (Fig. 16c4) appeared to co-precipitate with MP-conjugated beads. Although 
comparable amounts of MP were found exclusively in the pellet fractions, high levels 
of both tubulin and RNA could be detected in corresponding supernatant fractions (not 
shown), indicating that saturable binding had been achieved. At the MP:tubulinmonomer 
ratio of 1:1, one would expect the majority of tubulin to be found in the pellet fraction 
(Results section 3.4.4). Since this was not the case, it was speculated that either MP 
was incompletely conjugated to the affinity matrix (i.e. << 3.25 mM) or that upon 
refolding, only a subset of MP had retained tubulin binding activity. Nevertheless, in 
control reactions where MP was absent, neither tubulin nor RNA (Fig. 16b5 and c6, 
respectively) was detected in pellet fractions, which confirmed that co-precipitation of 
either component had only occurred due to an interaction with MP. When MP-
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conjugated beads were pre-incubated with tubulin before the addition of RNA, the 
amount of tubulin found in the pellet fraction was comparable to when tubulin was 
added alone (Fig. 16b2). However, the amount of detectable RNA in the pellet fraction 
was greatly reduced, which indicated that the MP:RNA interaction had been inhibited 
by the presence of tubulin (Fig. 16c2). Since RNA was able to bind MP in absence of 
tubulin, and indeed was present in a large molar excess over tubulin (when viewed in 
terms of nucleotides), it is likely that MP had a greater affinity for tubulin than RNA. 
In contrast, when RNA was incubated with MP-conjugated beads preceding the 
addition of tubulin, both components appeared to retain the capacity to interact with 
MP (Fig. 16c3 and b3, respectively), although to a lower level than when added alone. 
One possible explanation for this might be that tubulin out-competed RNA for an 
equivalent binding interface on the surface of MP. Although competitive effects cannot 
be ruled out, one might expect that at equilibrium, the level of pelleted material would 
be similar to when tubulin was added before RNA. Since both components were found 
in relatively high levels (and binding saturation had apparently occurred, not shown), it 
appeared that in fact a triple complex composed of MP, RNA and tubulin had formed. 
This being the case, it would suggest that although binding contacts essential for 
tubulin interactions were not entirely sequestered by the presence of RNA, there was a 
functional overlap between RNA and tubulin binding domains present within MP. 
Whether this putative molecular order of events would govern triple complex 
formation on the surface of polymerized tubulin, or indeed, whether such a complex 
would be viable in planta remains to be further analyzed. 
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Figure 16 Co-precipitation of RNA and tubulin heterodimers in vitro using 
immobilized MP as an affinity bait. Using a two-step approach, Ni2+-NTA beads 
conjugated to purified MP (theoretical max. 3.25 mM) were incubated in the presence 
of either a 6.7kb in vitro transcribed RNA (50 nM or ~300 mM polymerized nucleotide) 
or tubulin heterodimers (1.63 mM). Following this, tubulin, RNA or pulldown buffer 
were added to the beads, which were subsequently incubated and sedimented by 
centrifugation. Pelleted RNA was analyzed by 1 % non-denaturing agarose gel 
electrophoresis (c) and pelleted proteins were analyzed by SDS-PAGE and Western 
1 + MP Tubulin Buffer 
2 + MP Tubulin RNA 
3 + MP RNA Tubulin 
4 + MP RNA Buffer 
5 - MP Tubulin Buffer 
6 - MP Tubulin RNA 
Reaction     ± MP     1st component    2nd component 
1        2       3       4       5       6              1       2       3       4       5       6  
anti-MP                                           anti-a-tubulin 
2               3                4            6  
TMV-MP:GFP:(H)6  RNA (6.7 kb) 
(a) 
(b) 
(c) 
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blotting, using antibodies specific for MP and a-tubulin, respectively (b). The reaction 
combinations performed are summarized in Table (a) and correspond with the 
numbered lanes in (b) and (c). When added individually, both tubulin dimers (b1) and 
RNA (c4) appeared to co-sediment with MP, and in the corresponding supernatant 
fractions (not shown), detectable levels of both tubulin and RNA were observed which 
suggested that saturable binding had been achieved. In control reactions where MP was 
absent (reactions 5 and 6), neither tubulin nor RNA appeared to interact with the 
sepharose beads, confirming a direct interaction with MP had occurred in both cases. 
When MP-conjugated beads were pre-incubated with tubulin preceding the addition of 
RNA, almost saturable binding of tubulin appeared to occur (b2), although under the 
conditions used, the capacity of RNA to interact with MP was severely impeded (c2). 
In contrast, when RNA was introduced before tubulin, both components appeared to 
bind MP (b3 and c3), albeit to a lower level than when incubated alone with MP. 
Although inconclusive, these data suggest that at least in principle, an MP:RNA:MT 
triple complex is viable, and furthermore, residues within MP required for RNA 
binding may functionally overlap with those required to bind tubulin.  
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3.7 Apparent modulation of kinesin motor activity by MP 
Since it has been described that microtubule association of MAP2 and tau proteins are 
inhibitory to molecular motor activity both in vivo (Ebneth et al., 1998; Trinczek et al., 
1999; Stamer et al., 2002) and in vitro (von Massow et al., 1989; Lopez and Sheetz, 
1993; Hagiwara et al., 1994; Seitz et al., 2002), we speculated that the interaction of 
MP with MTs may confer a similar effect. In order to test this hypothesis, we utilized 
the so-called ‘MT gliding assay’ whereby conventional human kinesin-1 was absorbed 
onto a glass surface before fluorescently labeled MTs were introduced in the presence 
or absence of purified MP (Materials and Methods section 2.5). Kinesin motor activity 
was then initiated with the addition of ATP and the rate of MT translocation was 
measured using digital fluorescence microscopy (Fig. 17a) by determining the relative 
position of at least 30 MT ends at known time intervals (150 velocity 
readings/experimental condition). In addition, the percentage of MTs undergoing any 
translocation was calculated for each respective experimental condition. In the absence 
of MP, the average velocity of kinesin-dependent MT translocation was found to be 
0.20 ± 0.052 mm/sec (Fig. 17b), a value in agreement with previous reports (Seitz et al., 
2002). When 200 nM MP was added to the chamber prior to the initiation of kinesin 
motor activity, the average velocity of motile MTs was reduced to 0.16 ± 0.053 mm/sec 
(Fig. 17c), an interesting observation given that no discernible MP labeling on MTs 
was observed when equivalent MP:MT complexes were immunohistochemically 
labeled with an antibody specific for MP. Nevertheless, analysis of the mean values 
using a two-tailed unpaired t-test showed them to be statistically distinct (P<0.001, n = 
150), which indicated that MP affected a weak inhibition on kinesin-dependent MT 
translocation. A more pronounced effect on the rate of MT translocation was observed 
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when 600 nM MP was used (0.14 ± 0.058 mm/sec), and although statistically different 
than the mean velocity resulting from 0 and 200 nM MP treatments, respectively 
(P<0.01, n = 150), it was apparent that the range of translocation speeds had deviated 
slightly from a normal distribution (Fig. 17d). Visual analysis of animated MT 
translocations recorded under the described conditions (supplementary data: 
www.fmi.ch/members/jamie.ashby) showed that, although the majority of MTs 
appeared to smoothly glide across the chamber surface, a number of motile MTs 
underwent intermittent stalling when ³ 600 nM MP was used. Although stalling may 
account for the deviation from normally distributed data, it was apparent that due to 
this statistically irregular data spread at MP concentrations above 600 nM, reliable 
comparisons of average velocities could not be made. It should also be noted that, 
although not taken into account during velocity measurements, the percentage of motile 
MTs did appear to decrease concomitantly with increasing MP concentration (Fig. 17b-
d). Moreover, when MP was used at either 850 nM or 1.0 mm, the percentage of motile 
MTs had decreased so dramatically (30.4 and 4.0 %, respectively) that the measurable 
sample population for determining velocity was below a reasonable statistical 
minimum. Interestingly, visual analysis of the few MTs actually translocating indicated 
that kinesin motor activity was largely unaffected in those isolated cases 
(www.fmi.ch/members/jamie.ashby). It is possible that these particular MTs 
represented a subset of the population which were only partially decorated with MP. 
Although the presence of MP did appear to modulate the overall rate of kinesin-
dependent MT translocation, interpretation of these data with regard to the mechanism 
of inhibition remains somewhat tenuous. Under the experimental conditions applied, 
kinesin is predicted to be in a dimeric, processive form at a density of ~ 4000 
molecules/mm2 (Howard et al., 1993; Moyer et al., 1996). However, we have no 
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accurate knowledge of the polymerized tubulin concentration within the chamber. 
Visual comparisons before and after washing the chamber of unbound MTs showed 
that only a small percentage of introduced material actually adhered to the surface (not 
shown). Since each MT is therefore likely to be in favourable contact with several 
hundred kinesin molecules at any given time, one cannot determine whether inhibition 
arose due to a reduction in binding frequency between kinesin and tubulin, run length 
once bound or indeed modulation of kinesin motor activity itself. Current models for 
kinesin inhibition by microtubule-associated proteins favour a mechanism by which 
both proteins compete for equivalent binding contacts on b-tubulin, although once 
bound to the MT, kinesin is believed to translocate at normal rates (Lopez and Sheetz, 
1993; Seitz et al., 2002). It is unclear whether MP inhibits kinesin by a directly 
comparable mechanism, since if this were the case, one would not expect to observe a 
general decrease in MT translocation velocity at such a high density of kinesin. 
Although MP may indeed compete with kinesin for binding sites on tubulin, it remains 
plausible that the decreased rate of kinesin motor activity occurs by a more complex 
mechanism. In order for dimeric kinesins to translocate processively, one of the motor 
head domains must transiently dissociate from tubulin and move to the next available 
site in an ATP-dependent manner (Movie 6, www.fmi.ch/members/jamie.ashby). It 
could be speculated that the presence of MP on or in proximity to this second site 
imposes a steric constraint on such a kinesin motion, or moreover, directly impedes the 
so-called “power stroke” (Vale and Milligan, 2000). Intermittent stalling of MTs might 
then occur if one or more kinesin molecules are inhibited in this manner at a region of 
the MT which is decorated with particularly high levels of MP. Recovery from stalling 
might be orchestrated by the collective force of active kinesin motors which physically 
disrupt the non-motile kinesin:tubulin interaction or by displacement of the obstructive 
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MP. It was speculated that MP may directly bind to kinesin and inhibit motor activity 
by modulation of ATPase activity or steric hindrance. Although direct binding 
experiments are still required, preblocking of the perfusion chamber with 500 nM MP 
preceding the addition of MTs appeared to have a neglible effect on kinesin-dependent 
MT translocation, as determined visually (not shown). In addition, it was proposed that 
MP may bind non-specifically to the surface of the chamber, and at high 
concentrations, interact with MTs at stoichiometries sufficient to counteract kinesin 
force production i.e. anchor MTs to the surface. Non-specific effects of this nature 
cannot be discounted as the factor responsible for complete inhibition of motility at 
very high MP concentrations (> 600 nM), however, it is known that although MTs 
strongly adhere to plain glass surfaces, MT translocation can still be achieved if glass is 
preabsorbed with kinesin (von Massow et al., 1989). Nevertheless, further experiments 
utilizing very low kinesin amounts or even single molecules (Howard et al., 1989; 
Block et al., 1990) at known MP:tubulin ratios are required in order to determine more 
precisely the mechanism by which MP apparently inhibits kinesin-1 motor activity in 
vitro. 
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Figure 17 Apparent modulation of kinesin motor activity by MP in vitro. TRITC-
labeled MTs (110 nM polymerized dimers) were absorbed to perfusion chambers 
precoated with GST-conjugated kinesin-1 and either buffer alone (a and b), 200 nM 
MP (c) or 600 nM MP (d) were perfused through the chamber and briefly incubated. 
Following the addition of motility buffer+OS, images of “gliding” MTs were recorded by 
digital fluorescence microscopy, as illustrated in panel (a) and the velocity of MT 
translocation was determined by measuring the distance traveled by at least 30 
individual MTs every 1.25 seconds for 2 minutes. Mean values (" S.D.) were 
determined from the pooled data (150 measurements per sample) and the percentage of 
MTs that underwent any translocation were also calculated for each respective 
0 sec 
40 sec 
80 sec 
7 mm 
(a) (b) 
(c) 
(d) 
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experimental condition. As can be seen in panels b and c, upon the introduction of 200 
nM MP, the average velocity of kinesin-dependent MT translocation was reduced from 
0.20 " 0.052 mm/sec to 0.16 " 0.053 mm/sec, respectively. Comparison of these means 
using an unpaired t-test showed that they were statistically unequal (P<0.001, n = 150), 
thereby suggesting that MP had a weak inhibitory effect on kinesin motor activity at 
this concentration. A further decrease in motility rate was found when 600 nM MP was 
used (0.14 " 0.058 mm/sec), and although this figure was found to be statistically lower 
(P<0.01, n =150) than mean velocities resulting from 0 nM or 200 nM MP treatments, 
the data appeared to deviate slightly from a normal distribution. Irregularities in the 
data distribution became more pronounced when MP was employed at > 600 nM (not 
shown), and resulting mean values were not analyzed further. The  percentage of MTs 
undergoing any motility also appeared to decrease with increasing concentrations of 
MP and at 1 mm MP, almost complete inhibition of MT motility was observed. Due to 
the high density of kinesin molecules (~ 4000 molecules/mm2) and unknown tubulin 
concentration, it remains unclear as to the precise mechanism by which MP appeared to 
inhibit kinesin motor activity, however, these data may indicate that at low and high 
concentrations of MP, inhibition occurs via distinct modes of action. 
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4 Discussion 
The experiments described in this thesis were performed in an attempt to further 
characterize the association of TMV movement protein (MP) with microtubules (MTs). 
At the onset of these studies, the available experimental evidence indicated that the 
MP:MT interaction was functionally required for vRNA trafficking. Briefly, MP was 
observed to redistribute from ER-derived replication sites onto MTs (Heinlein et al., 
1998; Gillespie et al., 2002) and colocalize with vRNA at equivalent stages of infection 
(Más and Beachy, 1999). The appearance of MT-localized MP early during infection 
correlated with an increased rate of vRNA trafficking, and in cases where MP did not 
associate with MTs, intercellular vRNA spread was abolished (Kahn et al., 1998; 
Boyko et al., 2000a; Boyko et al., 2000b). Although these observations provide a 
plausible argument for MT-dependent vRNA transport, it remains unclear whether 
MP:MT complexes directly engage in vRNA trafficking, or indeed, why the 
association of MP with MTs is usually observed relatively late during infection. 
Nevertheless, MP associates with MTs in a number of cell types, and based on the 
findings of this thesis, is proposed to function as a structural microtubule-associated 
protein (MAP). Possible mechanisms leading to the MP:MT association, and the 
potential consequences of such an interaction during TMV infection are discussed. 
4.1 The MAP-like behaviour of MP 
Upon ectopic expression, MP associates with MTs in tobacco leaf epidermal cells, BY-
2 protoplasts, and COS-7 cells (Heinlein et al., 1998; Boyko et al., 2000a). The fact 
that viral replication and plant-encoded factors are dispensable for this association 
suggests that MP interacts with MTs in a specific manner, either by directly binding to 
tubulin, or via an accessory factor common to plants and animals. Furthermore, the 
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distribution of MP along MTs appears to be relatively uniform in most cases, which is 
consistent with the MT-localization of other MAPs known to directly interact with 
MTs, such as Tau in neurons or MAP65 in higher plants (Drewes et al., 1998; Lloyd 
and Hussey, 2001). Following the identification of a region within MP sharing apparent 
homology to a- b- and g-tubulins, it was proposed that MP may associate with MTs 
through a novel interaction involving ‘dynamic coassembly’ with polymerizing MTs 
(Boyko et al., 2000a). Although tubulin mimicry cannot be discounted as a possible 
mechanism for mediating MP:MT interactions, the binding of MP to MTs in vitro is 
found to be independent of MT polymerization. Taken together with the localization 
data, it would seem that MP exhibits the basic characteristics of a structural MAP, and 
conceivably, might even modulate MT-dependent processes. A fundamental property 
of structural MAPs is their ability to stabilize MT dynamics (Wiche et al., 1991). MTs 
initially form by the polymerization of tubulin dimers liganded to GTP. Through the 
hydrolytic activity of b-tubulin, GDP accumulates in the polymer structure and the 
resulting tubulin favors a curved configuration (Janosi et al., 2002). MTs are thus 
rendered unstable and will rapidly depolymerize unless capped with GTP-tubulin or 
otherwise stabilized (Panda et al., 2002; Caplow and Fee, 2003). Structural MAPs are 
thought to stabilize MTs by longitudinally crosslinking tubulin subunits and 
neutralizing the repulsive negative charges between dimers (Cassimeris and Spittle, 
2001). The molecular mechanism by which MP stabilizes MTs is not understood, 
however, both in vitro and in vivo, the localization of MP to MTs appears to correlate 
with the inability of monoclonal antibodies to recognize C-terminal epitopes on a- or 
b-tubulin. Although MAPs have also been shown to bind the C-terminus of tubulin 
(Al-Bassam et al., 2002), this apparent similarity to MP may be circumstantial given 
that MP shares no discernible sequence homology with any known MAP. Endogenous 
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MAPs interact with the acidic helices of tubulin by virtue of motifs rich in basic amino 
acids, and which are commonly arranged in tandem repeats (Olmsted, 1986; Downing, 
2000). In MP, a single 42 residue basic domain has also been identified by 
computational analysis (Brill et al., 2000). It has been demonstrated that deletion of 
this region leads to abolished MT association in TMV-infected plants (Boyko et al., 
2000c), and furthermore, this loss of MT binding corresponds with a change in the 
predicted net charge of MP:GFP from + 3.2 to – 2.8 at pH 7.5 (ProtParam, 
http://biobench.ph.chbs/aa/ProtParam/index.html). Although it is tempting to speculate 
that MP also binds MTs by ionic interactions, care should be taken when interpreting 
these findings, particularly as short N-terminal deletions and single point mutations 
outside of this basic region also confer a similar mislocalization of MP in vivo (Kahn et 
al., 1998; Boyko et al., 2000a; Boyko et al., 2000c). During infection, the events 
leading up to the association of MP with MTs are not fully characterized. Therefore, it 
could be argued that not all MP mutants are equivalent with regard to dysfunction, as 
the observed loss of MT association in vivo could have arisen through the disruption of 
other upstream processes. By testing the ability of such mutant proteins to bind MTs in 
vitro, it may be possible to discriminate between domains and/or residues within MP 
that are essential for MT binding, and those which are involved other mechanisms, 
such as ER- or Pd-targeting. As mentioned above, MAPs are thought to stabilize MTs 
by traversing tubulin subunits and physically holding them together. Considering that 
MP only contains a single putative MT-binding domain, and is significantly smaller 
than most MAPs, what  would explain the unusually high level of MT stability 
potentiated by MP? Perhaps the most attractive model involves the putative tubulin-
mimicry domain of MP (Boyko et al., 2000a). This region shares sequence similarity to 
the so-called tubulin ‘M-loop’, which is proposed to mediate lateral contacts between 
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tubulin protofilaments (Nogales et al., 1999). Although rather speculative, MP may 
have the ability to emulate M-loop binding contacts, and by an unknown mechanism, 
strengthen the inter-protofilament interaction or perhaps counteract the curling forces 
imposed by GDP-b-tubulin. A similar stabilization mechanism is thought to occur in 
response to the anti-mitotic drug taxol, which binds in proximity to the nucleotide-
binding domain of b-tubulin and makes interactions with the M-loop (Downing, 2000; 
Snyder et al., 2001).  However, because MP is larger than taxol by over an order of 
magnitude, one might expect that direct MP:tubulin binding contacts made at the 
protofilament interface would in fact be detrimental to the structural integrity of MTs. 
Certainly, one would expect to see aberrations within the microtubule lattice, but 
electron micrographs of MP:MT complexes assembled in vitro show filament 
structures to be relatively intact at low MP loads (not shown). Nevertheless, residues 
found within this mimicry domain of MP seem to be crucial for MP function, as 
disruption of this domain by point mutagenesis renders TMV temperature-sensitive 
with regard to cell-to-cell movement (Boyko et al., 2000a). An alternative hypothesis 
to explain MP-induced MT stability might be the ability of MP to form stable 
oligomeric homocomplexes. It is known that in vitro, purified MP has a propensity to 
form aggregates unless conditions of low ionic strength are employed or micelle 
concentrations of detergent are present in the buffer (Waigmann and Zambryski, 1995; 
Brill et al., 2000). Such oligomers were generally considered to have no functional 
relevance, however, it is conceivable that MP aggregation in vitro is simply a reflection 
of the chemical nature of this protein, and may represent a mode by which MP 
potentially ‘overloads’ MTs. Observations of MP:MT complexes in situ illustrate just 
how abundant MP is at the MT surface, and furthermore, immuno-gold labeling of 
MP:MT complexes formed in vitro has demonstrated that at high stoichiometries, MP 
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appears to form a sheath along the MT surface (not shown). Although further studies 
will be required to fully validate these findings, preliminary analyses indicate that these 
MP-derived structures are relatively uniform in size, and may be the result of a specific 
MP oligomer or at least an ordered, non-specific aggregate. Of course, the high levels 
of MP observed in association with MTs in vitro and in vivo may be the result of 
binding to sites other than the C-terminal helices. Supercomputer modeling of MTs 
using the Poisson-Boltzmann equation has revealed that much of the outer MT surface 
has a negative electrostatic potential and may be capable of interacting with the 
positively-charged MP (Baker et al., 2001). Given that MP:MT complexes isolated 
from TMV-infected protoplasts or assembled in vitro remain stable under conditions of 
high ionic strength, a purely electrostatic interaction seems less likely. Unfortunately, 
results from the biochemical analysis of MP:MT interactions in vitro do not resolve the 
question of MP-induced MT stability further than suggesting that MP forms oligomers 
and/or binds multiple sites on the surface of MTs. In order to better characterize the 
mechanisms that govern this interaction, it may be necessary to image the complexes 
formed during infection at very high resolutions, a technically challenging endeavor. 
4.2 MT-localization of MP in vivo 
Although a functional relationship between the association of MP with MTs and 
intercellular spread of TMV infection is established (Boyko et al., 2000a; Boyko et al., 
2000b), it remains unclear whether such MP:MT complexes can directly mediate 
vRNA transport. Furthermore, because MP exhibits the characteristics of a structural 
MAP, it has been suggested that late during infection, MP is involved in processes 
other than RNA trafficking. Nevertheless, vRNA transport appears to be somehow 
linked with the localization of MP to MTs, and therefore, further insight into the 
mechanism of MP-mediated RNA trafficking might be gained if one understands the 
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events which lead to formation of MP:MT complexes in vivo. During early stages of 
TMV infection, MP localizes to intersections of reticulated ER strands which 
subsequently aggregate to form large inclusion bodies. As infection proceeds into the 
mid stages, these large inclusions reduce in size and ER returns to a tubular form, 
concurrent with the appearance of MP in association with MTs (Heinlein et al., 1998; 
Reichel and Beachy, 1998). Because the smaller aggregates appear to align with MTs, 
it has been proposed that MP is directly redistributed from ER onto neighbouring MTs 
(Heinlein, 2002b). Interestingly, biochemical fractionation experiments indicate that 
MP behaves as an integral ER-membrane protein, and consistent with this finding, two 
potential transmembrane helices have been identified in MP by computational analysis 
(Reichel et al., 1999; Brill et al., 2000). Furthermore, according to the model proposed 
by Brill et al. (2000), the putative MT binding region of MP is predicted to be 
accessible to the cytoplasm, which might suggest that ER-associated MP contacts the 
MT surface directly. Protein mediated interfaces between ER and MTs have been 
described in other systems (Terasaki et al., 1986; Brandt et al., 1995; Isenberg and 
Niggli, 1998; Maas et al., 2000), and since MT-polymerization has been demonstrated 
to drive the modulation of tubulovesicular networks in Xenopus egg extracts 
(Waterman-Storer et al., 1995), a similar mechanism has been proposed for the 
translocation of ER-associated TMV vRNPs. The results of this thesis indicate that 
polymerization is not required for the association of MP with MTs, and therefore, 
might suggest that a motor-dependent ER-gliding mechanism is more appropriate 
(Waterman-Storer and Salmon, 1998), if it indeed transpires that vRNP trafficking is a 
membrane-based process. Regardless, it still remains unclear how MP can apparently 
redistribute from small ER puncta onto the entire length of MTs without being 
observed in ER strands. Since evidence exists that TMV replication can occur on ER 
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without the formation of visible inclusion bodies (Boyko et al., 2000c), it is 
conceivable that low levels of MP are actually transported through ER or translated 
proximal to MTs before accumulating on MTs to detectable amounts. Although ER-
trafficking of MP has not been demonstrated, evidence does exist to support the 
concept of divergent MP transport pathways. For instance, when constitutively 
expressed in transgenic plants, MP fails to localize to MTs although Pd targeting 
appears to be largely unaffected (Reichel et al., 1999). Although an interesting 
observation, Pd targeting alone is probably insufficient to support intercellular vRNA 
trafficking, since movement-deficient MP mutants unable to associate with MTs can 
still target and accumulate at Pd (Kahn et al., 1998; Boyko et al., 2000c). A possible 
link between the trafficking of vRNA and association of MP with MTs might be found 
when one looks at the mechanism by which other structural MAPs are deployed to 
MTs. In neurons, the axonal localization of Tau is dependent on 3’ UTR cis-acting 
signals that direct Tau mRNA-containing granules to axonal MTs by a mechanism 
thought to involve the MT-dependent molecular motor protein KIF3a (Litman et al., 
1994; Behar et al., 1995; Aranda-Abreu et al., 1999; Aronov et al., 2001; Aronov et 
al., 2002). Other RNA-containing transport granules have been shown to contain 
several proteins, and in addition, translationally repressed ribosome:RNA complexes 
(Bassell et al., 1998; Krichevsky and Kosik, 2001). In the case of Tau mRNA, it has 
been proposed that RNA movement and protein translation are interdependent 
mechanisms, although it is not clear whether Tau protein is synthesized by an axonal 
ribosome complex, or by co-transported factors (Aronov et al., 2002). Nevertheless, it 
would seem that mRNA transport is a prerequisite to MT binding of Tau protein and it 
could be speculated that TMV MP is deployed to MTs using a similar mechanism. A 
common feature of RNA localization appears to be that transcripts are translationally 
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repressed during transit and derepressed when the final destination is reached (Jansen, 
2001; Kloc et al., 2002). Although it is conceivable that TMV would have little 
requirement for such a regulatory mechanism, MP:RNA complexes formed in vitro do 
not appear to support translation unless MP is phosphorylated (Karpova et al., 1997; 
Karpova et al., 1999). These sites of phosphorylation have not been identified, 
however, it is interesting to note that upon isolation of detergent-resistant MT fractions 
from TMV-infected protoplasts, MT-associated MP is focused in at least 4 spots of 
equivalent molecular weight on 2D-PAGE gels, which is consistent with protein 
phosphorylation (not shown). Furthermore, addition of unmodified MP to MT-enriched 
plant extracts results in rapid MP phosphorylation (not shown), thus supporting the 
concept that MP and TMV-specific might be co-transported along MTs in a 
translationally competent manner. How then might this complex arise? Since 
ectopically expressed MP also localizes to MTs, other viral components and specific 
cis-acting elements within genomic vRNA appear to be dispensable. It is plausible that 
sequences present within the MP ORF directly connect the RNP complex to a pre-
existing transport complex, but because MP is translated from a subgenomic RNA, this 
would perhaps not fully explain the translocation of genomic vRNA. Alternatively, it 
may be possible that by virtue of cytoplasmically accessible domains, MP can directly 
interact with a motor protein and bud off from ER in the form of a ribosome-containing 
ER vesicle. A similar type of complex has been described to transport the dendrite 
localized developmental factor Pura (Ohashi et al., 2002), and may represent an 
analogous transport system to that proposed for TMV. Furthermore, preliminary 
observations of MP:GFP at very early stages of TMV-infection indicate that MP-
containing granules move within the cytoplasm at rates consistent with motor-
dependent trafficking. Although granule movement along microtubule filaments has 
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yet to be demonstrated, translocation does appear to occur in a saltatory, but directional 
fashion (Boyko et al., unpublished observations). If motor-based vesicular trafficking 
proves to be the mechanism responsible for vRNA movement, it would possibly clarify 
the apparently contradictory observations that MT is required for RNA transport, but 
the MP:MT complex is highly stable, and therefore, unlikely to support movement. It 
would be logical to propose that as vRNA is transported along MT networks in a 
granule, MP is constitutively translated, and due to its intrinsic ability to interact with 
MTs, accumulates on the MT surface. Preliminary evidence suggests that in vitro, MP 
does not directly compete with either Tau or MAP2 for equivalent binding sites, but 
can still apparently interact with  MTs. Although it cannot be ruled out that MP 
actually bound these MAPs non-specifically, this result indicates that a direct 
interaction between MP and MTs in vivo may indeed be possible. Furthermore, the 
MAP-like distribution of MP in vivo may actually be a consequence of vRNA 
transport, but plays a specialized secondary role during mid to late stages of infection. 
Certainly, it will be imperative to distinguish between early and late MP:MT 
interactions in order to understand intracellular vRNA movement. A possible way to 
achieve this may be to determine the relative localization of TMV RNA and MP in 
relation to MT and ER compartments following silencing of the genes encoding kinesin 
and kinesin-like proteins. Although a loss of TMV movement and MP/RNA 
localization to MTs could result from indirect cytopathic effects, this approach may 
provide circumstantial evidence to support motor-dependent transport. Additionally, it 
may be possible to identify factors involved in such a transport complex by 
biochemical fractionation of MP-containing granules or by immunoprecipitation 
experiments.  
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4.3 Role of the MP:MT interaction 
In most cases, MP can only be observed to associate with MTs in cells behind the 
leading edge of infection. Since the position of cells within the infection site indicates 
the temporal stage of viral infection, the MP:MT association is likely to take place 
following successful replication and cell-to-cell spread of the viral genome. 
Considering that MP may function as a MAP and that MP:MT interactions possibly 
represent a secondary feature of MT-based RNA transport, what possible role could the 
MP:MT complexes have during infection? Although rather open to interpretation, one 
suggestion is that MP provides a stable network of MTs along which viral trafficking 
can occur. Because MTs are highly dynamic, developmentally regulated organelles 
(Wasteneys, 2002; Shaw et al., 2003), such stabilization may conceivably prolong the 
ability of TMV to traffic its genome. Sustained vRNA transport would not seem to be 
an essential process, since the viral genome would have probably entered neighbouring 
cells prior to this event, however, subtle effects on the efficiency of TMV spread 
cannot be discounted. An alternative proposal has been that MT-associated MP is 
actually part of a host-directed degradation pathway. It has been demonstrated that MP 
is polyubiquitinated in TMV-infected protoplasts, and furthermore, ubiquitination is 
enhanced following the addition of 26S proteasome inhibitors (Reichel and Beachy, 
2000). Based on MP:GFP localization studies, inhibition of the 26S proteasome also 
leads to the apparent redistribution of MP from MTs to the ER-membranes of 
protoplasts and leaf epidermal cells during mid stages of infection (Reichel and 
Beachy, 2000; Gillespie et al., 2002). While it is highly likely that a host plant would 
attempt to defend itself against viral invasion using such a degradation system, certain 
aspects regarding the involvement of MTs are unclear. The fact that proteins destined 
for proteasomal degradation localize to the perinucleus (Hellmann and Estelle, 2002; 
  
113
 
Vierstra, 2003) may be incompatible with the organization of plant MTs. Following 
cytokinesis, MTs are certainly known to extend from the nucleus toward the cell 
cortex, however, throughout most of interphase, plant MTs are arranged cortically 
(Wasteneys, 2002). Furthermore, this cortical arrangement is commonly seen when MP 
is in association with MTs (Fig.14). It is claimed that because proteasome inhibition 
leads to MP distribution patterns consistent with a MP mutant enhanced in movement, 
ER-localized MP is indicative of protein that has evaded a MT-based degradation 
pathway (Gillespie et al., 2002). However, it is also likely that proteasome inhibition 
would result in an overaccumulation of ubiquitinated proteins that were unable to leave 
the targeting pathway because the destination complex was inactive. This would then 
suggest that 26S proteasome targeting of MP is mediated by ER during infection, and 
not MTs. When overexpressed in CHO cells and neurons, the structural MAP Tau is 
known to inhibit the kinesin-dependent trafficking of vesicles, ER and mitochondria 
(Ebneth et al., 1998; Stamer et al., 2002). Experimental evidence described in this 
thesis supports the concept that when abundant on the surface of MTs, MP also has the 
ability to inhibit kinesin motor activity. What impact this putative action would have on 
viral infection is far from understood, however, it has been speculated that by 
inhibiting endogenous MT-dependent trafficking, MP is somehow affecting a counter-
defense strategy. Sequence-specific RNA silencing has been proposed to function as a 
plant defense response against invading pathogens (Lindbo et al., 1993; Covey et al., 
1997; Ratcliff et al., 1997; Ratcliff et al., 1999). Once activated by the recognition of 
foreign nucleic acids, sequence-specific signals can spread systemically and direct the 
targeting and degradation of these RNAs. TMV is an RNA virus which appears to 
avoid the effects of gene silencing during infection. It is not clear how TMV evades 
this potent defense mechanism, and it may in fact relate to modulation of Pd or simply 
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the speed of viral movement. However, one proposal is that MP decorated MTs cannot 
support the trafficking of silencing signals, and thus reduces the effectiveness of 
silencing against viral replication. Since the exact nature of silencing signals, and the 
mechanism by which they traffic is not fully understood, it must be conceded that this 
theory is largely speculative. Nevertheless, it would be interesting to determine 
whether silencing responses against infection could be elicited by the introduction of 
short dsRNAs with sequence homology to TMV RNA, and furthermore, whether these 
responses related in any way to the level of MP in association with MTs.  
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Appendix I  Media and solutions  
 
Bacterial Media 
 
2 X YT bacterial growth media 
16 mg/mL tryptone 
10 mg/mL Bacto Yeast Extract 
5 mg/mL NaCl 
 
Luria Bertani (LB) Agar for bacterial plates 
10 mg/mL tryptone 
5 mg/mL Bacto Yeast Extract 
10 mg/mL NaCl 
15 mg/mL Agar 
 
Buffers used for Inclusion Body Isolation and Ni2+-NTA affinity 
chromatography 
 
Lysis Buffer 
20 mM Tris-CL, pH 8.0 
30 U DNase I (Ambion Inc.) 
10 mg/mL RNase A (Promega) 
2 X working strength Protease Inhibitor Cocktail, minus EDTA (Boehringer 
Mannheim) 
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Inclusion Body Wash Buffer 
20 mM Tris-CL, pH 8.0 
2 M Urea 
500 mM NaCl 
10 mg/mL RNase A 
2 % (v/v) Triton X-100 
1 X working strength Protease Inhibitor Cocktail, minus EDTA 
 
Solubilization buffer (SB5, 20 and 500) 
100 mM NaH2PO4, pH 7.5 
1 M NaCl 
10 mM Tris base (Used to reduce methionine carbomylation due to Urea) 
8 M Urea 
10 % (v/v) Glycerol 
Note: numbers denote the concentration of Imidazole (mM). 
 
Buffers used for binding and visualization of MP:MT complexes 
 
BRB80 (Brinkley Reaction Buffer) 
80 mM Pipes-OH, pH 6.8 
1 mM MgCl2 
1 mM EGTA 
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Kinesin binding buffer 
BRB80 containing: 
1 mM DTT 
10 mM Taxol 
0.25 mg/mL casein 
 
Kinesin wash buffer 
BRB80 containing: 
1 mM DTT 
10 mM Taxol 
0.1 % (w/v) BSA 
 
MAP binding buffer 
12 mM Pipes-OH, pH 6.85 
0.5 mM MgCl2 
10 % (v/v) Glycerol 
0.01 % (v/v) Tween-20 
10 mM Taxol 
 
Pulldown buffer 
40 mM Pipes-OH, pH 6.85 
0.5 mM MgCl2 
10 % (v/v) Glycerol 
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0.01 % (v/v) Tween-20 
5 mM Imidazole 
 
Buffers used for kinesin motility assays 
 
Motility Buffer 
50 mM Pipes-OH, pH 6.85 
 1 mM EGTA 
1 mM MgCl2,  
2 mM ATP 
10 mM Taxol  
150 mM KCl 
 
Minimal buffer 
50 mM Pipes-OH, pH 6.85 
1 mM MgCl2  
10 mM Taxol 
 
Oxygen Scavenger System 
Motility buffer containing: 
18 mg/mL catalase 
0.1 mg/mL glucose oxidase 
2.25 mg/mL D-glucose 
10 mM DTT 
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Appendix II Primers 
 
Primers for PCR amplication of the MP gene from plasmid pTf5-NX2  
 
Forward primer:  5’ gtttcgcgagcgctctagttgtt    3’ 
Reverse primer:  5’ cgaggtcaaggatccagcggcc 3’ 
 
Primers used for insertion of –(H)6 tags into plasmid pTf5-NX2 
 
TMV-MP:(H)6:GFP 
 
Sense strand:   5’  tcgacggttcccatcaccatcaccatcac    3’ 
Antisense strand:  3’  gccaagggtagtggtagtggtagtggatc  5’ 
 
TMV-MP:GFP:(H)6 
Sense strand:   5’  ggccgctcatcaccatcaccatcactaa     3’ 
Antisense strand:  3’  cgagtagtggtagtggtagtgattagct       5’ 
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Appendix III Mathematical and statistical models 
 
Saturation binding curve equations 
Assuming no chemical catalysis and the law of mass action, a simple bimolecular 
binding reaction can be described in the following way 
 
           (1) 
 
where [R] is the concentration of receptor (tubulin), [L] is the concentration of ligand 
(MP) and [RL] is the concentration of receptor:ligand complex. The probability of 
[RL] formation is proportional to k1[R] [L], where k1 is the association rate constant, 
and the probability of [RL] breakdown is proportional to k2[RL], where k2 is the 
dissociation rate constant, respectively. 
 
Thus, the rate of change of [RL] formation is proportional to the difference in rate 
constants. 
 
     ( ) ( )[RL]  [L] [R]  
t
]RL[
21 kk -=D
D
   (2) 
 
This relates to the free energy of binding in the usual way. 
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However, at chemical equilibrium, there is no change in the rate of [RL] formation. 
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Therefore, according to )(  RT G o aKln-=D  
 
   
d
a K
K
1
    
]L][R[
]RL[
==      (5) 
 
    aK [L] [R] ]RL[ =      (6) 
 
Where Ka is the association constant and Kd is the dissociation constant. 
 
 
At equilibrium, the amount of receptor fractionally bound by ligand (Y) is defined in 
the following way, where Rt is the total concentration of receptor and the law of mass 
action is assumed. 
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=       (7) 
 
 
Substituting [RL] for (eq. 6): 
 
a
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K
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Which simplifies to the Langmuir form (Scatchard, 1949): 
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And when written in terms of the dissociation constant: 
 
    
)([L]/  1
)([L]/
 Y
d
d
K
K
+
=  
 
Which can be solved for Kd: 
 
    
[L]  
[L]
 Y
+
=
dK
      (9) 
 
This takes the line form of y = ax/b+x. Plotting Y versus [L] yields a rectangular 
hyperbole where Kd is equal to [L] at half saturation. 
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1/2
[L]  
[L]
  
2
1
+
=
dK
      
    1/22/1 2[L] )]L[( =+dK  
    1/2[L] =dK       (10) 
    
In the case of a macromolecule, there may be multiple equivalent binding sites. Y is 
then substituted for v , which is the fraction of all receptors that are bound, assuming 
the intrinsic binding affinity for ligand is the same in all cases and the receptor sites do 
not interact with each other. 
 
 
[L]  
[L]n 
  v
+
=
dK
      (11) 
 
In practical terms, one can plot v  ([MP]bound) versus [L] ([MP]free), yielding a curve 
with the same shape as (eq. 8) and an equal value for Kd. Saturation occurs in this case 
at n, the number of equivalent binding sites. 
 
To determine whether non-equivalent, non-interacting binding sites exist on a 
macromolecule, eq. 10 can be expanded to a two-site model. 
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Plots of [L]bound versus [L]free are hyperbolic, but yield Kd and n values for each 
respective type of site. Binding data fit to a multiple-site model must be statistically 
compared to lower order models by analysis of variance (ANOVA) to ensure the  
strength of fit is not simply due to an increase in inflexion points. 
 
Linearization of equilibrium binding data 
The Scatchard-Rosenthal plot (Scatchard, 1949; Rosenthal, 1967) can be used as a 
visual aid in the interpretation of equilibrium binding data. Deviations from the 
predicted straight line give intuitive clues as to the mechanism of binding, e.g. whether 
multiple non-equivalent binding sites exist or whether equivalent binding sites display 
allosteric effects on subsequent ligand binding (cooperativity). 
 
The one-site equilibrium binding equation (eq. 11) can be manipulated in the following 
way to obtain the Scatchard form. 
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Plots of [L]bound/[L]free versus [L]bound give a straight line (y = mx + b) when the criteria 
for a single equivalent, non-interacting binding site are met. The slope equals -1/Kd and 
x-intercept equals n. Following transformation, data points (x-axis) do not conform to 
the Gaussian distribution, therefore, values for n and Kd are rendered unreliable. Bi- 
and multiphasic binding curves are indicative of multiple types of binding site and/or 
cooperativity of binding, although multivalent ligands or non-specific binding cannot 
be firmly discounted without further experimentation (Norby et al., 1980; Zierler, 
1989). 
 
Comparison of binding models by analysis of variance (ANOVA) 
One-way ANOVA is a statistical method which allows two or more groups of data to 
be compared according to the difference in the mean value between the groups and the 
degree of variability within the groups themselves. Since both equilibrium binding 
models (eq. 11 and 12) are related, it is possible to directly compare the strength of 
curve fit by calculating the F ratio in the following way, where SS is the residual sum-
of-squares (the difference between the observed and predicted curves) and df is the 
residual degrees of freedom or difference between the total number of samples and 
total number of adjustable parameters within the model (Motulsky and Christopoulos, 
2003): 
 
Null hypothesis (null): The simpler model is most appropriate 
Alternative hypothesis (alt): The more complex model is more appropriate 
 
altalt
altnullaltnull
/dfSS
)df - )/(dfSS -(SS
  F =ratio  
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In basic terms, this equation answers the question whether a perceived improved fit 
using a complex model is ‘worth’ the additional variables within the modeled term 
(decrease in degrees of freedom). F ratio values above 1 indicate that the complex 
model is statistically distinct from the simple model and fits the data more strongly. To 
determine the probability that random scatter within the data led to the complex model 
to fit better, one can calculate the P-value using the an automated algorithm (e.g. 
function =FDIST in Microsoft Excel 2000). P-values less than 0.05 (5%) confirm that 
the null hypothesis can be reasonably rejected. 
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Non-linear regression outputs (SigmaPlot 2001, SPSS inc.)  
One-site model 
 
Nonlinear Regression
[Variables]
x = col(1)
y = col(2)
[Parameters]
a = max(y) 
b = x50(x,y)
[Equation]
f= a*x/(b+x)
fit f to y
tolerance=0.000001
stepsize=100
iterations=100
R = 0.98341850 Rsqr = 0.967 Adj Rsqr = 0.963
Standard Error of Estimate = 0.4553 
Analysis of Variance: 
 DF SS MS F
Regression 1 54.8617 54.8617 264.6556
Residual 9 1.8657 0.2073
Total 10 56.7274
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Two-site model 
 
Nonlinear Regression
[Variables]
x = col(1)
y = col(2)
'Automatic Initial Parameter Estimate Functions
[Parameters]
a = max(y)/2 
b = .5*x50(x,y) 
c = max(y)/2 
d = 1.5*x50(x,y) 
[Equation]
f= a*x/(b+x)+c*x/(d+x)
fit f to y
tolerance=0.000001
stepsize=100
iterations=100
R = 0.99297596 Rsqr = 0.986 Adj Rsqr = 0.980
Standard Error of Estimate = 0.3368 
Analysis of Variance: 
 DF SS MS F
Regression 3 55.9333 18.6444 164.3483
Residual 7 0.7941 0.1134
Total 10 56.7274
 
 
Comparison of kinesin motility rates using the two-tailed unpaired 
students t-test 
When different groups of data conform to a Gaussian (normal) distribution and the 
variance of each group is the same (homoscedastic) , the t-test can be employed in 
order to determine whether each respective group has a significantly different mean (m) 
value. In principle, this is achieved by determining the probability that observed 
differences between the means are simply due to a high standard deviation (s), i.e. the 
result of variability within one or both groups, or actually arose due to a significant 
measurable difference. In the case of apparent kinesin motility rates, velocity data were 
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obtained from reactions performed at different times and with different batches of 
reagent. Therefore, the data groups can be considered to be independent and a two-
tailed unpaired t-test can be used with the null hypothesis (null) that the mean MT 
velocity of two groups is the same, and an alternative hypothesis (alt) that the means 
are different. The t-statistic was manually calculated as described below and when it 
was greater than the corresponding value obtained from a t-distribution with the same 
degrees of freedom, the null hypothesis was reasonably rejected. 
 
If both groups have the same sample number (n), one calculates the pooled standard 
deviation (S), where s is the standard deviation. 
 
2
)(
S
2
alt
2
null s+s=     (eq. 14) 
 
From this, the standard error (S.E.) of the difference between the means )( altnull m-m is 
calculated. 
 
altnull n
1
n
1
S.D.E.S +=    (eq.15) 
 
 
 
And finally the t-statistic is calculated thus. 
 
( )
.D.E.S
altnull m-m=t     (eq. 16) 
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The degrees of freedom equal (nnull + nalt) –2 and the corresponding critical t-values are 
read from a t-distribution table at 5, 1 and 0.1% confidence intervals, respectively. 
 
Calculated t-statistic values  
 
 Buffer 200nM MP 600 nM MP 
Mean velocity (m), mm/s 0.195 0.157 0.139 
Standard deviation (s) 0.052 0.053 0.058 
Variance* 2.7 x 10-4 2.8 x 10-4 3.4 x 10-4 
Sample size (n) 150 150 150 
 
 
Buffer versus 200 nM MP 
 
Null hypothesis: m (buffer) = m (200) 
t-statistic = 6.27 
tcritical (P = 0.05) = 1.96 
tcritical (P = 0.01) = 2.576 
tcritical (P = 0.001) = 3.291 
Conclusion: reject null hypothesis at 99.9% confidence level 
 
 
 
 
  
150
 
200 nM MP versus 600 nM MP 
 
Null hypothesis: m (200) = m (600) 
t-statistic = 2.81 
tcritical (P = 0.05) = 1.96 
tcritical (P = 0.01) = 2.576 
tcritical (P = 0.001) = 3.291 
Conclusion: reject null hypothesis at 99 % confidence level 
 
* To verify that variance values were sufficiently similar, an heteroscedastic (unequal variance) t-test 
was employed using Microsoft Excel 2000 software. The results of this analysis were fully consistent 
with the above t-statistic values, indicating that a pooled variance t-test was indeed the most appropriate 
for these data. 
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